Skip to main content

The model of local axon homeostasis - explaining the role and regulation of microtubule bundles in axon maintenance and pathology


Axons are the slender, cable-like, up to meter-long projections of neurons that electrically wire our brains and bodies. In spite of their challenging morphology, they usually need to be maintained for an organism's lifetime. This makes them key lesion sites in pathological processes of ageing, injury and neurodegeneration. The morphology and physiology of axons crucially depends on the parallel bundles of microtubules (MTs), running all along to serve as their structural backbones and highways for life-sustaining cargo transport and organelle dynamics. Understanding how these bundles are formed and then maintained will provide important explanations for axon biology and pathology. Currently, much is known about MTs and the proteins that bind and regulate them, but very little about how these factors functionally integrate to regulate axon biology. As an attempt to bridge between molecular mechanisms and their cellular relevance, we explain here the model of local axon homeostasis, based on our own experiments in Drosophila and published data primarily from vertebrates/mammals as well as C. elegans. The model proposes that (1) the physical forces imposed by motor protein-driven transport and dynamics in the confined axonal space, are a life-sustaining necessity, but pose a strong bias for MT bundles to become disorganised. (2) To counterbalance this risk, MT-binding and -regulating proteins of different classes work together to maintain and protect MT bundles as necessary transport highways. Loss of balance between these two fundamental processes can explain the development of axonopathies, in particular those linking to MT-regulating proteins, motors and transport defects. With this perspective in mind, we hope that more researchers incorporate MTs into their work, thus enhancing our chances of deciphering the complex regulatory networks that underpin axon biology and pathology.


Axons are the slender, cable-like extensions of nerve cells which form the nerves and nerve tracts that wire our brain and body, sending neuronal messages in highly regulated manners. With diameters of only 0.1-15μm [1], they extend over distances of up to a meter in humans. To adopt such a unique morphology and physiology, axons display many specialised features (Fig. 1).

Axons are indispensable for nervous system function, as illustrated by paralysis in spinal cord injury caused by the interruption of ascending and descending axon tracts [2, 3]. Axons are key lesion sites in injury-induced trauma and coma [4,5,6,7], and axon decay is believed to be an important trigger for neuronal decay in ageing and many neurodegenerative disorders [8, 9]. Notably, most neurons cannot be replaced, and compensation of lost axons through collateral branching of intact neighbouring axons has obvious limitations [9, 10].

This means that most axons have to be maintained for an organism's life time, i.e. up to a century in humans; unsurprisingly, mammals tend to lose almost half their axon mass towards high age [11, 12]. This trend is severely enhanced in neurodegenerative disorders, as illustrated by gradually increasing paralysis in spastic paraplegia or motorneuron disease [13, 14].

Research into neurodegenerative disorders typically approaches the problem by describing observed phenotypes and unravelling the molecular mechanisms performed by proteins linked to the disease. However, this approach rarely leads to satisfactory explanations of the pathology [15]. We believe that more profound understanding will arise when widening the scope from molecular to cellular mechanisms, by studying how proteins work within regulatory networks to underpin observable processes of axon biology - thus performing investigations at the same level of complexity at which pathology becomes manifest. Here we will illustrate this approach by focussing on the axonal cytoskeleton.

The importance of microtubule bundles for axon biology

As illustrated in Fig. 1, the cytoskeleton of the axon shaft consists of straight parallel bundles of MTs, which are interspersed with intermediate filaments (not shown [16]) and longitudinal actin fibres called 'actin trails' [17, 18] - all running through a sleeve of cortical actin [19] which is now known to consist of evenly spaced periodic rings; these rings have been proposed to consist either of short and adducin-capped actin filaments [20, 21] or of two long intertwined actin filaments [22]. Significant deviations from this organisation, not to be considered in this review, exist at axon initial segments (not shown in Fig. 1), growth cones and synapses [23,24,25,26].

Fig. 1
figure 1

Specific properties of axons. Axons during the growth cone stage are shown in (a) and after synaptic maturation in (b), differing primarily in certain stage-specific specialisations including growth cones, synapses, electrical properties and glial interactions (here myelination [389, 392]). The core machinery in the axon shaft can be expected to be similar at both stages: parallel continuous bundles of extended but discontinuous MTs run all along axons serving as a structural backbone (see Fig. 2), a transport highway for axonal trafficking (driven by motor proteins), and a source for 'off-track' MTs contributing to morphogenetic processes including branch formation, directed axon growth and synapse formation/plasticity (green, orange, blue curved arrows); MT bundles are interspersed with longitudinal actin trails [18, 24], continuous networks of (smooth) endoplasmic reticulum [44, 393], and other membranous organelles including mitochondria [45]; axonal membranes display regularly spaced periodic rings of cortical actin [20, 21], a high number of ion-specific channel proteins and transporters to conduct nerve impulses [394], as well as adhesions with external structures including fasciculating parallel axons (not shown), glial processes [395] and synaptic partner cells [396]; a degree of independence from cell-body derived proteins is provided by local translation machinery [397,398,399] or supply from surrounding glia cells (not shown; [400,401,402,403]). Note that the axon diameter in the region between glia cells in B (referred to as Node of Ranvier) usually has a much smaller diameter than the rest of the axon [1]

Of the three cytoskeleton classes, intermediate filaments were suggested by anatomical, developmental and genetic studies to regulate axon diameters, and their axonal aggregation is a hallmark of many neurodegenerative diseases [1, 27,28,29,30]. However, intermediate filament aggregations are not necessarily the cause, but can be the consequence of axon decay [30,31,32]. Notably, Neurofilament-H-lacZ mutant mice or Quiver mutant quail completely lack axonal intermediate filaments, but develop and breed fairly normally [33, 34]. Furthermore, various arthropods form axons of defined diameters in the absence of any axonal intermediate filaments [35,36,37]. In contrast to the moderate roles of intermediate filaments, actin and microtubules (MT) are essential for all stages of neuronal development and maintenance [37,38,39]. This review will be dedicated to the role and regulation of MTs.

Axons contain bundles of MTs that run along the entire length of their shafts (Fig. 1); these bundles are essential for axon biology in at least three ways (details in Table 1): as structural backbones (Fig. 2), as highways for axonal transport and organelle dynamics, and as source for splaying MTs that can contribute to axon morphogenesis or physiology. Maintaining MT bundles is therefore crucial for axon longevity. Accordingly, there are prominent and numerous genetic links from MT regulators to hereditary neurodegenerative disorders (Suppl. Mat. in [46]), and axon decay is a frequent side effect of MT-targeting chemotherapies [53,54,55,56].

Table 1 Roles of axonal MT bundles
Fig. 2
figure 2

Axonal response to mechanical challenges. Continuous bundles of discontinuous MTs which are flexibly cross-linked (likely involving slip-bonds) are thought to provide a structural element that can respond to different forms of mechanical impact (as indicated in blue)

Of particular interest for this review are reports of pathological axon swellings where MT bundles have disintegrated into loops or waves (bottom of Fig. 3), as observed in ageing, after injury and in certain in vivo models of axonopathies [7, 34, 57,58,59,60,61,62,63,64,65,66]. Notably, one study suggests that MT aberration upon ageing could cause swellings that trap and damage mitochondria, thus triggering axon degeneration [67]. However, MTs are surprisingly often ignored or side-lined in existing studies of axon pathology and there are simply not enough data to deduce meaningful correlations between axon degeneration and MT bundle decay. But even if this were to reveal a close correlation, this still would not exclude that, depending on the pathological condition, MT bundle deterioration may be a mere consequence rather than cause of axon decay (details in Fig. 4). Ultimate clarification will only arise from developing a better understanding of MT bundle-forming and -maintaining machinery. Here we propose a conceptual framework that may facilitate such developments.

Fig. 3
figure 3

An interactome of MT-regulating and -associated mechanisms expected to contribute within the model of local axon homeostasis. Developing and mature neurons are shown at the bottom indicating that the close-up (magenta frame) might apply in both contexts. 1-16) Potential mechanisms that can 'tame' MTs into bundled conformation: MT polymerisation (blue stippled arrows) is driven by molecular machinery centred on Eb1 (blue balls), further influenced by the tubulin supply machinery (not shown) and shaft-binding proteins (7); polymerisation generates new MTs required for bundle formation (8) and turn-over (14); to integrate into bundles, extending MTs require guidance via actin-Eb1 cross-linkage along the axonal surface (5; Shot) or along pre-existing MTs through MT-MT cross-linkers (9; brown L). The same or other cross-linkers provide the structural glue that holds MT bundles together (12; brown L); some of them can also bind to actin (2), they protect from (or recruit) MT severing activity (15), and influence motor protein dynamics (a). MTs which have escaped any cross-linkage are inhibited by cortical collapse factors when approaching the axonal surface (4; Efa6) or by MT-severing factors at MT-MT cross-points (6). The bundled MTs are discontinuous; their free minus ends are stabilised by CAMSAP/Patronin (Ptrn) together with katanin (black scissors; 13), whereas non-polymerising MT plus ends are stabilised by other factors (not shown; e.g. CLASP or the Dynactin subunit p150/Glued [404, 405]). The dynein/Dynactin complex is believed to link cortical actin to MT bundles and drive them anterogradely (10), whereas Ptrn at minus ends may anchor MTs via spectraplakins to the axon cortex (1); spectraplakins may also link MTs directly to cortical actin (2) or to transmembrane receptors (3), and they are expected to perform further, still unexplored actin-independent bundle-promoting roles through their PRR domains (11). Tear-and-wear damages MTs (dashed green line), potentially affecting interaction with MT-binding proteins (16; red X); MT severing proteins might selectively eliminate such MTs (16; scissors), or MTs undergo repair (not shown). Nucleation of MTs (17) is mediated by ɣTuRC directionally anchored to MT lattices via the augmin/HAUS complex (AUG). A-E) Mechanisms closely 'associated' with MT bundles: MT-associated motor proteins ('motor', solid orange arrows) drive axonal transport of (protein-loaded) vesicles (A), cytoplasmic factors including proteins, translational machinery (ribosomes) or RNAs (B), move other MTs (B, sliding), and position/rearrange organelles including mitochondria (C, mitos), endoplasmic reticulum, peroxisomes and endosome (D) - and this likely includes mitochondrial fission and fusion (E). a-e) The motor-associated functions all act downstream of MT bundles because they require them to walk on; but they also act upstream: for example, the forces they generate (stippled orange arrows) are the potential cause for MT disorganisation (buckling shown in d); transport delivers important regulators and building blocks for bundle-maintaining processes (b); the proper regulation of organelles/endocytic compartments provides systemic factors that can orchestrate MT bundle-taming mechanisms, including intracellular free calcium or reactive oxygen species (Ca2+, ROS; yellow cloud [202, 203]) as well as ATP required for many processes including actin dynamics, MT severing and MT motor activity (red stippled arrows; note that vesicular transport uses glycolysis to generate its own ATP; yellow star); vice versa, the MT severer spastin also regulates the ER through ATP-independent mechanisms (e), and MT-associated proteins (APC) regulate local translation events (c)

Fig. 4
figure 4

MT bundle defects as cause or consequence of axon decay. 1) Disease-inducing mutations/conditions can affect a MT bundle regulator (e.g. dystonin [90]), thus causing MT bundle defects first which, in turn, can trigger axon decay. 2) Disease-inducing mutations/conditions can affect systemic factors which, in turn cause MT bundle defects as an intermediate causative step in the cascade leading to axon decay (e.g. axonal transport fails, leading to MT bundle defects which then contribute to axon decay, as is the case in Alzheimer's disease or ALS [302, 406, 407]); this may occur even if MT regulators are affected, but these regulators mainly act in the cell body (e.g. dysregulation of the Golgi [408]). 3) MT bundle deterioration may be a mere consequence of axon decay, although this case will be difficult to disentangle from option 2, since MT bundle disintegration and axonal disassembly may occur in parallel, as observed in developmental or injury-induced axon degeneration [409,410,411]). All MT-related phenotypes in this graph are indicated with a frame

From work in Drosophila to the integrated model of local axon homeostasis

The foundations for this conceptual framework were laid when we took the decision to use the fruit fly Drosophila melanogaster as a means to study how cytoskeletal regulators collaborate in orchestrating the morphogenetic changes that drive axon growth [68]. Drosophila is certainly not a miniature human, but it has many advantages and provides powerful means to uncover the regulatory concepts behind the roles and regulations of axonal MTs, which then often apply to higher organisms (Table 2; [15, 69,70,71]). Through using Drosophila neurons as a consistent, standardised cell system, our group alone performed functional analyses of over 50 actin- and/or MT-binding or -associating regulators ([46]; unpublished data); these studies form an unprecedented pool of data on the basis of which to develop novel concepts [21, 72,73,74,75,76].

Table 2 Why use Drosophila?

For example, loss-of-function conditions of 24 MT-binding or -associating (2nd order) proteins that we analysed in cultured primary neurons, revealed MT disorganisation in more than half the cases. Interestingly, the MT disorganisation found in these various conditions appears to display certain common characteristics: axons display areas in which their bundles are dissolved into chaotic, intertwined, crisscrossing arrangements of curled MTs (see examples in Fig. 5). These phenotypes were surprising when considering that MTs usually behave like rigid rods [84,85,86]. Notably, when using some of the same genetic conditions in vivo, comparable phenotypes were observed in the fly brain [74]. Such in vivo phenotypes in the fly are reminiscent of the curled MT conformations in pathological axon swellings of mammalian models mentioned in the previous section. Potential evolutionary conservation of this phenomenon is further supported by the occurrence of similar MT curling and disorganisation in mouse and rat primary neurons [87, 88] - and we are certain that more reports will emerge once researchers consider MT disorganisation to be a phenotype worth quantifying.

Fig. 5
figure 5

Disorganisation of axonal MTs upon loss of different MT regulators in Drosophila primary neurons. a Normal neuron (wild-type, wt) with soma (asterisk), axon shaft (curved arrow) and growth cone (tip of most distal MT indicated by arrow head). b Eb15 mutant neuron where the area of MT disorganisation is framed by a red stippled box and shown as close-up on the right. c-e Similar close-ups shown for Efa6GX6[w-], Khc27 and shot3 mutant neurons. Note that the four mutated factors perform fundamentally different molecular functions, with Eb1 being a MT plus-end binder ('8' in Fig. 3), Efa6 a cortical collapse factor ('4' in Fig. 3), Khc a kinesin-1 motor protein ('A-E' in Fig. 3) and Shot a multi-functional cross-linker ('1-3, 5, 11' in Fig. 3). All neurons were derived from wild-type or homozygous mutant embryos, mechanically and chemically dissociated, kept for 7 days in pre-culture in a centrifuge tube to deplete any maternal gene product, mechanically and chemically dissociated again, cultured on concanavalin A-coated glass coverslips for 1day at 21°C, fixed and stained with anti-α-tubulin (DM1A, Sigma; procedures detailed elsewhere: [78]); images were taken by A.V. using STED (stimulated emission depletion) microscopy. Scale bar in A represents 10 μm for the two neurons and 4 μm in close-ups

As an attempt to explain the occurrence of this MT phenotype across mutant conditions and animal groups, we developed the model of 'local axon homeostasis' [37, 89], based on two fundamental elements:

(1) The model proposes that MTs in axons show a strong bias to become disorganised and curl up. As detailed further below, this is most likely induced by the force-generating motor proteins that drive transport of large cargoes in the narrow axonal environment crowded with physical obstacles posed by organelles and protein complexes (Fig. 1, 'A-E' in Fig. 3). Once MT disorganisation occurs, e.g. through off-track polymerisation or buckling ('4' and 'd' in Fig. 3), it can form a seed that gradually develops into pathological axon swellings.

(2) The model further proposes that this risk is contained through the actions of different classes of MT-associating and -regulating proteins, which co-operate and complement each other to form robust machinery that 'tames' MTs into bundles ('1-17' in Fig. 3).

In this model, each axon segment uses locally acting MT regulators to maintain its MT bundles (hence 'local axon homeostasis'). Hereditary or acquired loss of single regulators would be expected to weaken this machinery and increase the statistical risk of MT disorganisation. Such heightened probability might explain why many axonopathies affect primarily long axons [54], and why certain disorders linked to MT regulators display late onset of axon decay [90].

In the next two sections, we discuss potential causes explaining the bias of axonal MTs to become disorganised. We will then summarise experimentally demonstrated MT bundle-maintaining mechanisms, and speculate about further mechanisms based on existing knowledge of known classes of axonal MT-regulating proteins.

Understanding the unusual curling behaviours of MTs in axons

Although curvature is a key driver of MT plus end dynamics during de-/polymerisation [91, 92], MT lattices in vitro usually behave as rigid rods with a persistence length of 1-10 mm (as compared to 12 μm measured for actin filaments [84,85,86]). MTs are polar polymers composed of α/ß-tubulin heterodimers which are arranged in a head-to-tail fashion into linear protofilaments; usually 13 of these protofilaments are laterally aligned forming a straight tube of roughly 25 nm outer diameter (Fig. 6a, c). But MTs can deviate from this norm, and this may be one factor introducing an intrinsic bias towards disorder: for example, axonal MTs were reported to contain 13 protofilaments in frog olfactory or goldfish brain axons, but 11 or 15 in C. elegans, and 12 in certain neurons of Drosophila, crayfish and lobster [66, 93,94,95]. Deviation from the straight 13 protofilament conformation appears to equip MTs with functionally relevant physical properties [96, 97]. But it also introduces a skew into the MT structure, which causes a supertwist of the tubule (Fig. 6d [98,99,100]); this supertwist forces motor proteins to rotate around MTs [101] and is a potential explanation for supercoil of entire axons observed under destabilising conditions [83, 102].

Fig. 6
figure 6

A molecular perspective of microtubule properties. a Cross-section of a MT with 14 protofilaments (PF) and lateral view of a 13 PF MT, both in B-lattice configuration, where α-tubulins make lateral bonds with α-tubulins and ß with ß, except at the seam (magenta line: seam; dashed red line: PF). b Close-up of an α/ß-tubulin heterodimer showing the various post-translational modification sites as indicated; note that the GTP of ß-tubulin in lattices is usually hydrolysed (GDP). c A 13 PF MT (top), cut open at the seam and rolled out (bottom); the yellow line shows the diameter, the white line follows the helical rise of laterally bonded tubulins; in 13 PF MTs, tubulins are precisely aligned at the seam (yellow arrow head) but shifted by three positions (3-start helix). d When deviating from the 13 PF prototype, tubulins are misaligned at the seam (orange arrow head); when forced into alignment, the PFs skew (deviation of the magenta line from the white stippled line), causing a super-twist of the MT as described by the 'lattice accommodation model' [98, 412]; for certain PF numbers, MTs can form two alternative alignments, of which usually the version with the lower helix start value (left) has a left-handed super-twist, whereas the higher value is right-handed [98]. e MTs behave like rigid rods with a persistence length of up to 10 mm, but can be bent down to diameters of curvature of ~1μm before they break; it has been reported that their cross-sectional profile may flatten above a certain threshold (black arrow head), thus softening the tube. f Lattices of GDP-tubulin are 1-3% shorter than MTs that were polymerised with the non-hydrolysable GTP analogue GMPCPP, or stabilised with taxol (orange structure binding α-tubulin in a 1:1 ratio, according to [413]); binding of kinesin-1 causes similar lengthening of tubulin (and additional compactions in the tubulin structure: yellow stars) which may cause cooperative binding of further kinesins and induce curvature if occurring only on one side of the MT; in extended taxol-bound MTs, bending forces were suggested to change tubulins on the concave side into their short conformation as an energetically favoured condition. For further references see main text

Furthermore, MTs are structurally active: their physical properties can change when proteins bind to them (e.g. kinesins, see below) or when the 'tubulin code' is altered. The tubulin code is determined by the incorporation of different existing isotypes of α- and ß-tubulin into the MT lattice, and the addition of a range of distinct post-translational modifications (Fig. 6b [103,104,105,106]). Some modifications influence the interaction with MT-binding proteins (e.g. poly-glutamylation attracts spastin and tau [107, 108]). Others are believed to structurally protect MTs from damage or depolymerisation: for example, poly-aminations on various residues stabilises against depolymerisation [109], or acetylation of luminal lysine 40 makes MTs more flexible and break-resistant (Fig. 6b; [110,111,112,113,114]). Notably, site-directed mutation of lysine 40 in Drosophila α1-tubulin was able to demonstrate that intraluminal MT acetylation is physiologically relevant [115, 116]. In addition, the MT lumen may contain MIPs (MT inner proteins) that likely also modify MT stability [117].

These intrinsic or acquired physical properties are likely to determine how MTs respond to external forces - and we can expect such forces to be highly enriched in axons (see next section). Some ideas about how forces may impact on axonal MTs can be derived from in vitro experiments. For example, MTs in flow chambers that are anchored at one end, will bend when applying flow and rapidly return to straight confirmation when flow is stopped; if certain shaft-binding proteins (e.g. doublecortin or non-motile kinesin-1) are added, MTs become locked in bent conformation and fail to re-straighten [118,119,120].

Another example is provided by so-called in vitro gliding assays, where MTs are moved around on carpets of active motor proteins. On carpets of (axonemal) dynein, MTs move plus-end-first; they undergo collisions at high frequency, but seem to stay fairly straight and form vortices at the millimetre scale [121]. In contrast, if similarly prepared MTs are on kinesin carpets, they move minus-end-first and undergo fewer collisions because they can pass over one another, likely owed to the adaptable length and dynamic MT binding properties of kinesins [121,122,123,124]. However, if they collide or become pinned to the substrate (e.g. by dead kinesins) they can undergo dramatic shape changes including fishtailing and arc or loop formation at the micrometre scale [125,126,127]. The smallest diameters of curvature observed are similar to those of curled MTs in axons with values as low as 1-3 μm (Table 3, Fig. 5; [87, 88]) - and below 1μm MTs are believed to break [128, 129].

Table 3 MT loop or spool formation in gliding assays under different conditions. Footnotes: a) Primarily the lower range of mentioned diameters is listed; b) not clear from experimental section; c) measured from images. Abbreviations: CW, clockwise; CCW, counter-clockwise; polym, polymerisation; SA, streptavidin; tub, tubulin. References: (1) [126], (2) [134], (3) [138], (4) [137], (5) [130], (6) [135], (7) [136], (8) [414], (9) [133], (10) [132], (11) [415], (12) [121]. Note that a number of mathematical models were put forward to describe loop or spool dynamics in gliding assays [141, 156, 157, 414, 416, 417]

If MTs on kinesin carpets are reversibly cross-linked with biotin-streptavidin, they coalesce into bundles containing dozens of MTs which frequently curl up into spools with inner diameters similar to those of loops (details in Table 3). Spools can take on similar appearances as looped MT bundles observed in growth cones of fly or mammalian neurons [77, 130, 131]. Furthermore, single MTs can escape from spools which may trigger spool disassembly [130, 132, 133], bearing some resemblance with off-track MTs leaving axonal bundles ('4' in Fig. 3).

Parameters known to influence loops and spools in vitro might provide mechanistic insights into similar behaviours of MTs in axons (details in Table 3). Firstly, loop formation is favoured by high density of MTs and/or kinesins [134, 135], i.e. conditions that are clearly given in axons. Potential explanations are offered by reports that kinesins directly impact on the structural properties of MTs (see below), but they can also cause pinning events in gliding assays, which could be seen as a potential proxy for the abundant obstacles faced by extending or sliding MTs in the narrow axons. Secondly, higher MT rigidity results in larger diameter curls and spools in gliding assays [136]. Thirdly, right- versus left-handed supertwist of the MTs involved in gliding assays determines whether curls and spools have a clockwise or counter-clockwise directionality (Fig. 6d; [132, 137]). Furthermore, exposure to non-polar interfaces (e.g. n-heptane or air bubbles) induces strong curling [138], and this may be relevant in axons: changes in physical and chemical parameters of neurons upon ageing or in degenerative diseases promote liquid-liquid phase separation [139]; liquid compartments likely are of low polarity [140] and might therefore influence the curling bias of MTs. All these parameters observed in vitro can be expected to apply also in axons and might contribute to the observed curling behaviours (Fig. 5).

MT loops in gliding assays can be surprisingly stable (frequently >5 mins, as reported in [134]). To explain this, it has been proposed that tubulin-heterodimers on the concave side of the tube take on a shorter conformation than those on the convex side, and that this asymmetric distribution can be maintained as an energetically favoured state (Fig. 6f, bottom right [141]). Conformational length variations underlying this model were observed in non-hydrolysed GMPCPP-MTs where tubulins are 1-3% longer than hydrolysed GDP-tubulin; taxol added after (but not during) polymerisation achieves a similar elongation (Fig. 6f; [142,143,144,145,146]). Notably, this conformational length change seems physiologically relevant, as its suppression by the T238A mutation in yeast ß-tubulin stabilises MTs in vivo and causes mitotic defects [147, 148].

Such intrinsic properties of MTs may contribute to MT curling in axons, further influenced by MT lattice-associating proteins, such as tau, doublecortin or kinesin-1 which were reported to bind differently to curved versus straight MTs [118,119,120, 149,150,151]. In particular kinesins-1 was shown to extend MT lattices to similar degrees as taxol [120] through mechanisms that involve local compaction of tubulin different from taxol- or GMPCPP-induced effects [152, 153]. Since kinesin-1 has a preference for convex MT surfaces and was reported to undergo cooperative binding, this may lead to a curvature-enhancing and -stabilising snowball effect with an estimated diameter of curvature of 3.2 μm [120, 154, 155]. In this way, kinesin carpets in gliding assays might induce stable yet reversible curling, as has been suggested by mathematical modelling (top right in Fig. 6f, [156, 157]).

Naturally, current models are in their infancy and further findings need to be incorporated. For example, MTs behave as elastic cylinders (comparable to a garden hose) and can undergo softening through cross-sectional flattening when strongly bent (Fig. 6e [158, 159]). In this same vein, conformational changes of MTs upon kinesin-1 binding were reported to soften MTs locally [160]. If confirmed, this would have important implications for any existing models; together with the kinesin-induced tubulin compaction (yellow asterisks in Fig. 6f), it might be a mechanism to absorb energy and reduce the shear force load on MTs. Notably, softening of MTs is also observed upon taxol application (usually used in gliding assays; Table 3 [144]) or MT acetylation (abundant in axons [111, 114]), and might be a common prerequisite for curling behaviours.

To conclude, loop and spool formation in gliding assays are considered processes of 'active self-organisation' [125]. We strongly feel that this term might apply also to the formation of MT disorganisation in axons, and that potential mechanisms underlying MT curling in axons can be learned from in vitro assays. Notably, motor proteins, in particular kinesins, are being highlighted as key factors in both gliding and flow chamber assays. In the next section we will therefore summarise roles of kinesins during axon pathology.

The intricate relationship between MTs and their associated motor proteins

Several kinesins display direct roles in MT regulation [161]: they may promote MT polymerisation (kinesin-2, -5 [162,163,164]), drive MT depolymerisation (kinesin-8, -13 [165]), stabilise MT-minus ends (kinesin-14 [166]), cross-link MTs (kinesin-5, -6, -12; see section on bundling), and regulate MT orientation as a feature of neuronal polarity [167,168,169].

However, in axons most attention is usually given to cargo and organelle transport/dynamics (Fig. 3a-e; see section on axonal cytoskeleton) driven retrogradely by the minus end-directed dynein/Dynactin complex, and anterogradely by plus-end directed kinesins (primarily kinesin-1, -2, and -3 [40, 170]). The forces imposed by these dynamics and/or the size of cargoes moved in the constrained environment of axons rich in physical obstacles, poses an obvious challenge to MT bundles [171] and might be an important factor leading to MT disorganisation.

Clearly, there is an intricate mutual regulatory relationship and finely tuned balance between the amount of transport and the structural properties of MT bundles as the transport highways [23, 171]. Thus, MT bundle properties influence transport: firstly, MT density is higher in small calibre axons than in large axons, with MT numbers and densities ranging to enormous degrees (4-130 MTs per axon, ~4-150 MTs/μm2); correlative studies and mathematical modelling suggest that higher MT numbers promote axonal transport ([172,173,174] and references therein). How MT numbers are so precisely controlled is an important but entirely unresolved issue that likely involves the nucleation machinery (see section on nucleation/polymerisation). Secondly, MT length correlates with transport rates [81]. Thirdly, the tubulin isotype composition of MTs, their posttranslational modifications, and the physical presence of certain MT-binding proteins influence motor protein dynamics ('a' in Fig. 3; [149, 175,176,177,178,179,180]).

Vice versa, transport affects MT bundles: for example, binding of kinesin changes the physical properties of MTs (see previous section), and binding and buckling through motor proteins cause damage to the MTs they walk on, triggering maintenance responses including MT repair or potentially even replacement ('14' in Fig. 3; [120, 181,182,183,184,185]). Close links between MT organisation and transport are also illustrated by charge-changing mutations in the H12 helix of C. elegans α-tubulin, reported to impact on axon transport whilst causing MT bundle aberrations [66].

Tipping the balance in this mutual relationship can easily be imagined to cause reciprocal deficiencies in transport rate and MT bundle organisation. For example, disorganisation or partial breakage of MTs has been reported to cause pathological transport deficits (option '1' in Fig. 4; [7, 67]). Furthermore, the space required for large cargo movements is likely generated through dynamic rearrangements of local MT-MT crosslinking networks (see section on cross-linkage); in this scenario, deviating from the right amount of cross-linkers may be a path to bundle aberration. Vice versa, demyelination upon immunological lesioning [186, 187], was reported to initially cause transport defects, which were then followed by MT disorganisation ('2' in Fig. 4; [60]). Analogously, we observe that loss of certain transport kinesins (Kinesin heavy chain/Khc/Kif5A or B, Unc-104/Kif1A) causes severe MT disorganisation in Drosophila primary neurons (Y.T.L. and A.V., unpublished data; Khc shown in Fig. 5e).

How loss of these kinesins may cause MT disorganisation can currently only be hypothesised. There are potential biomechanical and/or biochemical explanations. For example, it has been reported for dendrites that kinesin-1 migrates on acetylated and kinesin-3 on tyrosinated MTs [167]. Provided the same is true in axons, the loss of kinesin-1 would relieve acetylated MTs, but tyrosinated MTs would still bear their full transport load - and vice versa. Such imbalances in transport distribution within MT bundles could lead to shear forces that buckle MTs and seed MT disorganisation. Similar mechanisms may explain why MT disorganisation was observed at the axon initial segment upon directional changes in motor traffic caused by deficiency of the dynein regulator NDEL1 [188].

Loss of kinesins could have impact on MTs also through biochemical routes. For example, the bundle-maintaining machinery may simply suffer from aberrant supply of cargoes including (a) tubulin heterodimers as building blocks, (b) the MT-binding proteins that execute MT bundle maintenance work ('b' in Fig. 3), or (c) organelles which can be expected to play major roles in MT bundle maintenance (see Table 4 for details).

Table 4 The intricate relationship between MTs and axonal organelles

Functional interdependencies between transport and MT organisation provide potential explanations for a number of observations. For example, they may explain why axonal swellings induced by senile plaques in the Tg-swAPPPrp mouse (overexpressing an amyloid precursor protein carrying a familial Alzheimer's disease-linked mutation [189]) were strongly enhanced when removing one copy of the KLC1 gene (kinesin light chain; a linker required for kinesin-1 mediated veciscular transport) - and this effect is conserved in Drosophila [190]. They may explain why different types of Charcot-Marie-Tooth disease or hereditary spastic paraplegias can be caused through motor proteins as well as regulators of membranous compartments [191, 192]. They may also explain why MT-stabilising drugs can be beneficial in animal models of neurodegeneration as diverse as SPG4 (Table 4) and Alzheimer's disease [193, 194].

Naturally, the argumentative framework presented here is highly speculative, given the enormous complexity of the relationships between MT bundle organisation, motor protein activity and organelle-dependent systemic factors. But we hope that these reflections will motivate experimenters to have a closer look at MTs in future studies of axon biology and pathology, and include statements in their reports as to whether MTs are affected. More data are urgently needed, which does often not require more than analysing neuronal morphology with antisera against tubulin (rather than restricting to intermediate filaments), or having a closer look at MTs in ultrastructural studies by increasing the resolution. In the following sections we will explore the mechanisms that are potentially used to form and maintain MT bundles against the odds of motor-induced aberration or damage.

MT nucleation and polymerisation as fundamental requirements for bundle maintenance

The de novo formation of MT bundles during developmental, plastic or regenerative axon growth ('8' in Fig. 3) requires MT nucleation and polymerisation. Also in axons of mature and fully grown neurons, MTs undergo nucleation and polymerisation [37, 218], for example to drive MT repair and/or turn-over in order to maintain a steady state and prevent MT senescence ('14' in Fig. 1; [183, 184]). A well-regulated machinery of MT nucleation/polymerisation and disassembly is therefore needed to keep the numbers of healthy axonal MTs in balance with the transport load (see previous section; [172]).

Mechanisms of MT nucleation have long been known to be independent of centrosomes [219, 220] and should therefore involve cytoplasmic assembly or non-centrosomal MTOCs (MT organising centres; [221, 222]). For example, tau was reported to form condensations on MTs in vitro [179, 180], and such condensed phases of tau could theoretically have nucleation capacity [223, 224]. Furthermore, new MTs could arise from MT fragments (see Section on severing proteins below), potentially anchored via CAMSAP (calmodulin-regulated spectrin-associated protein)/Patronin to polymerise in the accurate direction towards the axon tip [113, 225]. Best demonstrated so far are mechanisms dependent on ɣTuRC (ɣ-tubulin ring complexes) and their anchorage via augmin/HAUS complexes to MTs ('17' in Fig. 3): depletion of either ɣ-tubulin or different HAUS proteins causes severe axon shortening and reduction in MT density; in addition, HAUS depletion causes polarity defects reflected in frequent MT polymerisation events towards the soma [226,227,228], suggesting that regulated nucleation is doubly important for axonal MT bundle maintenance. As the underlying mechanism it has been proposed that the augmin/HAUS complex anchors ɣTuRC to other MTs and points them distally ('17' in Fig. 3), and such a view is consistent with live imaging in Drosophila S2 cells [229].

The machinery of MT de-/polymerisation (blue stippled arrows in Fig. 3) requires at least three sub-machineries [37]: (1) dynamic protein complexes at the MT plus end that directly regulate polymerisation (blue balls, 'Eb1' in Fig. 3); (2) a complex regulatory network that supplies mature α/β-tubulin heterodimers as building blocks and that is closely co-regulated with MT dynamics ('B' in Fig. 3; [230,231,232]); (3) proteins binding or post-translationally modifying MT lattices that have impact on plus end dynamics, for example by stabilising MTs against depolymerisation or by promoting rescue ('7' in 'Fig. 3).

The fine-tuning of the net rates of MT nucleation and polymerisation appears to depend on complex regulation. For example, we recently found that loss of cortical actin rings in the axon shaft of Drosophila primary neurons (Fig. 1) caused a reduction in MT polymerisation speed, eventually affecting MT bundle integrity; simultaneous genetic or pharmacological destabilisation of MTs exacerbated these effects, frequently even eliminating entire axons [21]. Similar dependencies of MT polymerisation on actin networks are suggested by other reports: (1) parallel loss of spectrin and tau causes a reduction in axonal MT numbers in C. elegans [83]; (2) axon-shortening induced by the MT-stabiliser taxol can be ameliorated through co-application of actin-destabilising drugs (in both chick and Drosophila neurons [77, 233]); (3) application of actin-destabilising drugs changes the tubulin-to-microtubule ratio in PC12 cells [234] and causes axon retraction in chick dorsal root ganglia neurons ([235]; see also Table 5). Explanations for the mechanistic links from actin networks to net MT polymerisation remain speculative: they might involve biochemical pathways since cortical actin rings have recently been reported to act as signalling hubs [236], or might work through biomechanical mechanisms (see Table 5).

Table 5 Biomechanical models of axon growth

Maintaining MT bundles through cortical guidance and elimination of polymerising MTs

Whilst MT nucleation and polymerisation are essential for axon formation and maintenance, they also pose a risk: for example, extending MTs may be obstructed by the abundant organelles or protein complexes in axons, thus causing accidental 'off-track' MTs that project out of the bundle towards the cortex ('4' in Fig. 3). Apart from MT buckling, off-track MTs may therefore be a second cause for axonal MT disorganisation.

A key factor preventing this from happening is Eb1 (end binding protein 1; Figs. 3 and 5b; [75]). Eb1 directly binds at extending MT plus ends where it promotes polymerisation [237] and serves as a scaffold for many other proteins [238]. Upon absence of Eb1 in Drosophila primary neurons, MTs are severely disorganised, indicating important roles in MT bundle maintenance (Fig. 5B [75]). One underlying mechanism is the guidance of polymerising MTs through binding of Eb1 to Short stop (Shot); Shot is a well-conserved spectraplakin, able to cross-link cortical actin, MTs and Eb1 ('5' in Fig. 3), thus guiding polymerising MTs in parallel to the axonal surface and laying them out into parallel bundles [75]. Accordingly, also loss of Shot causes severe MT disorganisation in fly axons (Fig. 5e) - and the same is true for functional loss of its two mammalian homologues ACF7 and dystonin in culture and in vivo [57, 59, 87, 90]. Of these, dystonin mutations link to the axonopathy HSAN6 (type 6 hereditary sensory and autonomic neuropathy [239]).

Cortical guidance is complemented by at least one quality control mechanism [74]: MTs that have (accidentally) left their bundled arrangements and extend towards the cortex in Drosophila neurons, get inhibited by Efa6 (exchange factor for ARF6; '4' in Fig. 3). Efa6 is a cortical collapse factor that associates with the axonal membrane via its C-terminal plekstrin homology domain and blocks MT polymerisation via its N-terminal MTED (MT elimination domain); when Efa6 is absent, off-track MTs outside axonal MT bundles persist for longer and are higher in number. Consistent with the known roles of off-track MTs in axon growth, branching and MT disorganisation (see Table 1 and above), fly neurons in culture and in vivo lacking Efa6 display longer axons, more branches and prominent MT disorganisation (Fig. 5d [74]).

Our model would predict that mutant phenotypes caused by loss of Shot and Efa6 should enhance each other because they are caused through complementary mechanisms of MT bundle regulation. Accordingly, we found enhanced MT disorganisation when removing both Shot and Efa6, and over-expression of Shot could rescue Efa6 mutant phenotypes [74]. We propose therefore that Shot and Eb1 keep MTs away from the membrane, whereas Efa6 acts as a quality control factor inhibiting occasional accidental off-track MTs. This elimination seems to occur in moderate, well-balanced amounts so that 'intended' off-track MTs required for axon growth and branching can persist and perform their function.

Interestingly, the cortical collapse function of fly Efa6 is not conserved in vertebrates [74]. Nevertheless, the concepts derived from Efa6 studies appear relevant, because loss of the unrelated neuronal cortical collapse factor KIF21A (kinesin family member 21A; a type 4 kinesin) causes analogous phenotypes in mammalian neurons. Thus, KIF21A mutations linked to the neurodevelopmental disorder CFEOM1 (type 1 congenital fibrosis of the extraocular muscles) affect axon growth and axonal branching just like Efa6 [74, 263] - and might as well cause MT disorganisation, but no data are currently available.

However, guidance along cortical actin seems not the only mechanism through which Eb1 and Shot keep MTs on track. This is illustrated by the simple fact that MT disorganisation observed upon loss of Shot or Eb1 in primary fly neurons (Fig. 5b, e) does not occur when removing actin from axon shafts [21, 75, 77]. This suggests that both factors perform additional, actin-independent functions or interactions to promote MT bundles.

For example, the unusual Shot-PH isoform, which is highly enriched in the nervous system and harbours a plakin repeat region (PRR; conserved in mammalian spectraplakins), is a likely candidate for such roles that still await investigation ('11' in Fig. 3; [79, 90]). Apart from spectraplakins, Eb proteins have a long list of further interactors [238], and some of them might associate with MTs and guide extending plus ends along pre-existing bundles ('9' in Fig. 3); for example, APC (adenomatous polyposis coli) or GAS2-LIKE family members are good candidates, known to bind both MTs and Eb1 in mammals and Drosophila [264,265,266]. In this context, Eb1-APC-kinesin complexes were already suggested to contribute to MT guidance [169, 267]. Furthermore, MT guidance through septins might offer new explanations for axonal growth defects observed upon septin deficiencies [268,269,270].

Potential roles of severing proteins and MT-destabilising kinesins in MT bundle maintenance

Apart from cortical MT elimination, also MT severing and/or depolymerisation in the cytoplasm may play important roles in maintaining axonal MT bundles. This is supported by axonal MT disorganisation observed upon the losses of Drosophila katanin (Y.T.L., unpublished results) or mammalian spastin [62,63,64,65].

As explained in the previous section, MTs leaving the bundled conformation can drive axonal growth, branching and MT disorganisation, and cortical collapse factors negatively regulate all three processes. In line with this argumentation, also Kif2A (a MT-depolymerising kinesin-13 family member; [271]) and MT severing proteins (spastin, katanin and fidgetin) were reported to inhibit neurite growth and/or branching [272,273,274]. However, other studies of spastin, katanin and fidgetin led to contradictory findings, describing them as promoters rather than inhibitors of neurite growth and branching [63, 275,276,277,278,279,280,281,282]. Such stark, potentially context-dependent deviations reflect the complex regulation of these proteins.

Spastin, katanin and fidgetin are all members of the superfamily of AAA proteins (ATPases associated with diverse cellular activities; [201, 283, 284]), but their severing activity is differentially regulated through their individual responses to (a) posttranslational MT modifications (in particular acetylation and poly-glutamylation; [107, 274, 285,286,287,288]), (b) competition with other MT shaft-binding proteins such as tau ('15' in Fig. 3; [275, 289, 290]), or (c) spatial recruitment through specifically localised proteins such as CAMSAP ('13' in Fig. 3 [291]). Furthermore, katanin has the ability to depolymerise MTs in an ATP-independent manner [292].

Through this context-dependent spatiotemporal regulation of their activities, severing proteins can have two diametrically opposed outcomes: they either eliminate MTs, or they break them up into stable fragments that may serve as seeds for MT amplification [113, 201, 293]. In the following, we will briefly speculate how either of these outcomes could be used to prevent MT disorganisation:

First, MT severing proteins could complement roles of cortical collapse factors ('4' in Fig. 3) by serving as quality control factors that eliminate disorganised MTs within the cytoplasm ('6' in Fig. 3). For example, katanin in plant cells was reported to localise and sever preferentially at MT cross-points, which can be used to take out non-aligned MTs [201].

Second, MT shortening functions of katanin are required at MT minus ends. Thus, in both mammals and Drosophila, the minus-end capper CAMSAP/Patronin protects against MT disassembly, and recruits katanin to counterbalance against uncontrolled minus-end polymerisation ('13' in Fig. 3; [225, 291, 294]); uncontrolled minus end extension upon katanin deficiency may cause MTs to go off-track or potentially buckle through extra forces produced. Note that CAMSAP3 also plays roles in maintaining non-acetylated MTs, thus further complicating interpretations [295].

Third, MT elimination functions could prevent MT bundle senescence. For example, MTs suffer from damage through tear-and-wear [120, 181,182,183, 185], which might cause bundle aberration by abrogating interactions with MT-binding proteins (red cross at '16' in Fig. 3). MT fractures or holes can be repaired through mechanisms involving katanin or spastin [183, 232, 293, 296, 297]. However, more subtle features of senescence (e.g. irreversible modifications, loss of tubulin C-tails) might require selective elimination of ageing MTs through severing factors (as similarly suggested for kinesin-8 or -13 [298]) which could then trigger compensatory polymerisation ('14' in Fig. 3). For example, spastin deficiency in the SpΔ mouse model caused a drop in MT polymerisation (potentially reflecting reduced turn-over) accompanied by a rise in MT disorganisation (potentially caused by precocious MT senescence; [65]).

However, the MT phenotypes observed in the SpΔ mouse model could likewise be explained through the opposite role of spastin in promoting MT multiplication through generating nucleation seeds: in the absence of such a function, MT numbers might gradually decline and cause transport interruptions and eventually axonal pathology (see section on motor proteins; [214, 299]). Curiously, axon swellings in the SpΔ mouse model were reduced with low doses of MT-stabilising or -destabilising drugs [65], thus failing to provide any clues as to whether spastin works through MT turn-over or amplification in this context.

Understanding spastin is important because it is by far the most prominent factor linking to spastic paraplegias worldwide [300, 301], and axonal swellings are a hallmark of the disease [192, 302]. Most SPG4-linked mutations lie within the AAA-ATPase domain [303], suggesting that MT severing is key to the disease pathology. However, point mutations might generate versions of spastin, which either act as dominant negative alleles (forming dysfunctional complexes that titrate out other spastin-interacting factors), or acquire gain-of-function qualities by diffusing away to perform very different roles. One such MT-independent role of spastin is the isoform-specific regulation of the endoplasmic reticulum ('e' in Fig. 3), including its shape, its interaction with the endosome and its production of lipid droplets [304,305,306,307]. It is therefore difficult to exclude that at least part of those SPG4-linked mutations triggers axon decay through other routes than the direct induction of MT aberrations ('2' or '3' versus '1' in Fig. 4).

Potential roles of MT-MT cross-linkage in MT bundle maintenance

MT-MT cross-linkage appears an obvious means of suppressing MT disorganisation ('12' in Fig. 3) and is likely the oldest mechanistic concept put forward by neurobiologists to explain MT bundles [16, 308, 309]. Mathematical models support MT-MT cross-linkage as an important structural feature of axons (e.g. [310,311,312,313]), and physical cross-linking strands of varying length between axonal MTs were observed decades ago [16, 314]. Such MT-MT cross-linkers would be expected to detach upon super-threshold pull or compression, and re-attach thereafter (Fig. 2; slip-bonds), giving axons properties approximating those of active fluids (K. Miller, personal communication). However, the molecular players mediating MT-MT cross-linkage in axons remain surprisingly controversial to this day [315], as briefly explained in the following.

First, showing that a neuronal linker expressed in non-neuronal cells induces MT bundling, is insufficient proof: MT bundling can even be achieved through expression of isolated MT-binding domains, or the application of the MT-stabilising drug taxol; intriguingly, taxol-induced bundles display ultrastructural cross-bridges that are indistinguishable from those induced by tau or MAP 2 [308, 316,317,318,319]. As a further example, dynamin is linked to Charcot-Marie-Tooth disease and has been shown to bundle MTs in vitro; however, the physiological relevance of this is questionable, because dynamin in vivo seems to bind primarily membranes [320,321,322].

Second, neurofilaments were reported to fill spaces between MTs especially in larger diameter axons and to form lateral extension that link to MTs around them [323]. However, as mentioned in the second section, lack of neurofilaments is not a lethal condition, suggesting that cross-linking roles of intermediate filaments are not crucial in axons.

Third, MAP 1B appears an ideal cross-linker at first sight, because it possesses an N- and a C-terminal MT-binding domain, but it is not a convincing bundler when expressed in non-neuronal cells [324] - although the Drosophila homologue Futsch was reported to promote MT spools at synaptic terminals [325]. We are aware of only two reports mentioning axonal bundle defects upon loss of MAP 1B or Futsch [326, 327] and another where loss of Futsch reduces the spacing between axonal MTs [328]. Rather than MT bundle structure, most insights into MAP 1B/Futsch functions concern axon development, which likely reflects its major role [324, 329,330,331]. Another candidate with N- and C-terminal MT-binding domains is MTCL1 (microtubule cross-linking factor 1) which displays prominent bundling activity when expressed in non-neuronal cells and is prominently expressed at the AIS (axon initial segment) of cerebellar Purkinje cells [317, 332, 333]. Ultrastructural analyses of a range of neuron types have revealed that MTs at AISs are not distributed throughout the axonal lumen as observed along axon shafts, but are grouped up into parallel sheet-like arrangements cross-linked by ~25nm long spacers ('Axon' chapter in [334]). In Purkinje cells, these parallel arrangements are affected upon loss of MTCL1, as is in agreement with its proposed role as cross-linker [332]. However, due to its limited expression in the cerebellum, MTCL1 cannot explain similar sheet-like arrangements in the AISs of other neuron types. A more likely candidate is TRIM-46 (tripartite motif-containing protein 46) which is expressed in AISs in many nervous tissues, contains only one central MT-binding domain, can induce sheet-like arrangements when expressed in non-neuronal cells, localises to the cross-bridges, and its knock-down in cultured neurons causes reduced cross-linkage [335, 336].

Fifth, the conserved linker candidate tau, has one central MT-binding region and seems to achieve physical MT-MT linkage through N-terminal dimerisation [337,338,339]. However, its dwell time on MTs is very short [150, 340]. Similar to MAP 1B/Futsch, we are aware of only rare reports of fairly mild bundle aberration upon loss of tau [83, 341], and most tau-deficient phenotypes concern neuro-developmental defects instead [331].

Pinpointing roles of tau or MAP 1B/Futsch in axonal MT-MT cross-linkage is enormously complicated by the fact that both proteins seem to perform a whole array of further molecular functions relevant for MT dynamics. For example, tau can protect MTs from severing by katanin [289], bind tubulin hetero-dimers [342], switch between bundled and single MT states [343], cross-link MTs with actin or the cortex [344,345,346,347], stabilise MTs [315, 348], maintain labile domains along MT shafts [290, 349], regulate end-binding proteins [350], compete with kinesins or regulate their traffic [179, 180, 351], and promote MT nucleation and polymerisation [331, 352]. A similarly broad functional pleiotropy has been reported for MAP 1B [324].

Gaining experimental proof for MT-MT cross-linking activities in axons is also complicated by functional redundancies. For example, enhanced phenotypes are observed when mutations of MAP1B and tau or of spectraplakins and tau are combined in the same neurons, or when Futsch and Tau are co-expressed. Such functional redundancies likely extend to further potential cross-linkers. For example, kinesin-5 (KIF11), kinesin-6 (KIF23, Pavarotti in Drosophila) and kinesin-12 (KIF15) slide anti-parallel MTs in the mitotic spindle [354]; since axonal MTs are arranged in parallel, these kinesins seem therefore to inhibit sliding in this cellular compartment [355,356,357,358,359,360], suggesting that they cross-link MTs. In support of this idea, we observe that loss of Pavarotti causes axonal MT disorganisation in Drosophila primary neurons which might reflect potential linker function (Y.T.L., unpublished data).

In conclusion, MT-MT cross-linkage is a long proposed concept, but pinpointing the responsible molecular factors in axons remains a key challenge. We seem to have come a step closer at the AIS, but are far from understanding the situation in the axon shaft. We even cannot fully exclude a model where MT bundles are held together by the corset of contractile cortical actin rings (Fig. 1), and cross-linkers merely separate MTs to generate space for transport [241, 309]. It is therefore pivotal to decipher the true molecular nature of MT-MT spacing/cross-linkage in axons; overcoming functional redundancies between different classes of linker candidates might be an important strategy to this end.

Does MT bundle maintenance involve their anchorage to the axonal surface?

Apart from cross-linking MTs within axonal bundles, they might also be anchored to the axon wall, as a further means to prevent MT buckling and bundle deformation caused by the enormous forces imposed by axonal cargo transport. For example, axolinin in squid giant axon has been discussed as a potential MT-cortex linker [361]. Certainly, large ankyrin isoforms can anchor MTs to the cortex at the AIS of mammalian neurons [25, 362, 363] and along axon shafts in Drosophila [328]. In the case of Drosophila it was proposed that MT-cortex linkage through ankyrin combined with spacer function of the MAP 1B homologue Futsch (which contains an unusual central domain of 60 repeats with neurofilament homology [329]) form networks that sustain a large axon diameter, thus replacing roles of neurofilaments in mammals (see above).

Relevant in this context is the phenomenon of slow (ca. 0.5-5mm/day) somatofugal flow of MTs in developing axons, first observed in 1940 using axonal constrictions [364] and later confirmed in vertebrates and flies alike [365,366,367,368]. Forces contributing to this process could be derived from an increase in MT volume through polymerisation along the axon shaft [77], pulling forces in the rear of growth cones [246], thermal motion of MT-MT cross-linkers [369], kinesins actively sliding MTs along other MTs ('B' in Fig. 3; [370]), or dyneins sliding MTs along cortical F-actin ('10' in Fig. 3; [88, 258, 371, 372]).

Potential MT sliding along cortical actin would represent one form of tethering MT bundles to the axonal surface. Such anchorage is also suggested by observed co-drift of the axolemma with the axon core [248, 251, 373]. But anchorage would not have to be static; for example, it might involve an interface of slip-bonds, as similarly suggested for actin networks that flow across, whilst dynamically anchoring to, stable focal adhesion sites [374]. MTs could anchor to cortical actin (Fig. 1; '2' in Fig. 3; [20]) or to membrane-associated or transmembrane proteins including ion channels, ion transporters or adhesion factors (Fig. 1; '3' in Fig. 3). Links to transmembrane proteins could be used as mechano-sensing modules [375] that measure local shear forces generated between MT bundles and the axonal environment (Fig. 1). Such mechano-sensing properties could explain local regulation phenomena: for example, net rates of mitochondrial movement along the axon are fairly constant, but the slow transport component (driven by MT bundle flow) is low in proximal and high in distal axon segments; this gradual increase in the amount of slow transport is compensated for by inverse proportional amounts of fast transport (high proximal, low distal [366]). This well-balanced regional amount of fast mitochondrial transport could potentially be regulated by mechano-sensing, i.e. measuring the local MT drift rate relative to the outer axonal environment in each axon segment.

Apart from dynein (see above), other potential anchoring mechanisms can be deduced from the literature. For example, spectraplakins are good candidates, as suggested by distal shift of axonal MTs in fly neurons lacking the Drosophila spectraplakin Shot and treated with the MT-stabilising drug taxol [90]. Three distinct mechanisms could account for spectraplakin-mediated MT anchorage: Firstly, spectraplakins could directly cross-link actin and MTs ('2' and '5' in Fig. 3). Secondly, they could link to membrane-associated proteins; for example, the mammalian spectraplakin dystonin can link to ß4-integrin and transmembrane collagen XVII ('3' in Fig. 3; [90]), and Drosophila Shot is able to regulate the axonal localisation of the cell adhesion molecule Fasciclin 2, potentially cross-linking Fasciclin 2 to MT bundles [376, 377]. Thirdly, spectraplakins were shown, in non-neuronal cells of fly and mammals, to anchor MT minus ends to the cortex ('1' in Fig. 3; [225, 378, 379]); this mechanism requires interaction with the MT minus end-stabilising factor CAMSAP/Patronin, a factor that is known to be relevant for neuronal morphology [380].

Also other MT-binding proteins, such as tau, MAP1B, APC and dynamin, might be involved in anchorage since they were also reported to bind to actin or to the cortex ('2' in Fig. 3; [324, 344, 346, 347, 381,382,383,384]). Potential MT-actin cross-linkage in the axon may not only occur at the cortex, but as well at central longitudinal actin trails (Fig. 1; [17, 24]), thus further contributing to the intricate cross-linking networks expected to stabilise MT bundles. Deciphering MT bundle cross-linkage, internally or with the axonal surface, stays a major challenge for future research, but its understanding will teach us important lessons about axon biology and pathology.

Conclusions and future perspectives

Here we have presented a conceptual view by describing our vision of a functional interactome of cross-regulatory networks acting at the local level in axons. This model sits right at the interface of research into molecular mechanisms and modern bioinformatics approaches of functional network analysis. We propose that there has to be a fine balance between damaging effects inflicted by life-sustaining motor movements ('associated', 'A-E' in Fig. 3) and those factors that maintain the highways required for this movement (MT-'taming' mechanisms; '1-17' in Fig. 3); both are fine-tuned through a number of cross-regulatory mechanisms ('a-e' in Fig. 3).

Our model integrates a broad range of findings from the literature. But its original foundations are derived from our own work in Drosophila neurons, as a consistent cellular system in which it is feasible to study a wide range of genetic factors in parallel and in combination, as a means to understand redundancies, hierarchies and cooperation [46, 70, 72]. This offers unique possibilities to tackle the daunting task of disentangling the enormous complexity of axonal MT bundle regulation. For this, the model of local axon homeostasis could provide a useful basis, helping to develop testable working hypotheses; a good starting point might be to break down the local axon homeostasis machinery into classifiable sub-machineries, like those discussed in the different sections of this review.

This approach also means that we need to recognise the value of incremental long-term approaches that gradually assemble known and newly discovered molecular mechanisms into an integrated understanding of how axon biology is orchestrated at the cellular level, i.e. the organisation level at which axonopathies become manifest. As B.A. Cohen put it: "Research that results in models that reliably and quantitatively predict the outcomes of genetic, biochemical, or pharmacological perturbations should be valued highly, and rewarded, regardless of whether such models invoke novel phenomena" [385].

For the studies of MTs in neurons, we need to take into consideration that knowledge derived from non-neuronal cells might only partly apply [72]. Furthermore, the interactome shown in Fig. 3 makes clear that we will need quantitative approaches: we know increasingly well how factors bind to MTs and partly understand how they might compete with each other. But how crowded can a single MT be, how many molecules are there in its surrounding at any time point, and how much dynamic exchange is taking place? Computational modelling will be an unavoidable means to make sense of existing data and make reasonable predictions to inform experimentation [386, 387].

Integrated understanding of axon biology will also improve our knowledge of the next higher level of complexity, i.e. the signalling networks and systemic factors (e.g. second messengers, ATP, ROS, the 'tubulin code' [104, 113, 212, 388]) that govern axon homeostasis and that maintain balance even during phases of change (e.g. when switching from growth to differentiation, or during stress, injury, regeneration) - or that tip the balance and induce degeneration in disease or ageing. Also the roles of glial cells, likely acting as important external influencers of such systemic processes [389], will become clearer.

Finally, MTs have been recognised as promising therapeutic targets [302, 390, 391], and urgently needed advance on this translational path will be facilitated by a better understanding of the axonal MT homeostasis system. A larger focus of the research community on MTs and, in turn, an improved availability of MT-related data that can be incorporated into our understanding, would be a key prerequisite to make such progress.

Availability of data and materials

Data sharing not applicable to this article as no datasets were generated or analysed during the current study.



ATPases associated with diverse cellular activities


Actin cross-linking factor 7


Adenomatous polyposis coli


Calmodulin-regulated spectrin-associated protein


type 1 congenital fibrosis of the extraocular muscles


End binding protein 1


Exchange factor for ARF6


ɣ-tubulin ring complex


type 6 hereditary sensory and autonomic neuropathy


induced pluripotent stem cell


Kinesin heavy chain


Kinesin family member


Kinesin light chain


Microtubule inner proteins




Microtubule elimination domain


MT organising centres




Plakin repeat region


Reactive oxygen species


Short stop


Spastin-linked spastic paraplegia


Stimulated emission depletion


  1. 1.

    Hoffman PN. Review : The Synthesis, Axonal Transport, and Phosphorylation of Neurofilaments Determine Axonal Caliber in Myelinated Nerve Fibers. Neuroscientist. 1995;1:76–83.

    CAS  Article  Google Scholar 

  2. 2.

    Bichenback J. International perspectives on spinal cord injury. WHO, ISCOS: Switzerland; 2013.

    Google Scholar 

  3. 3.

    Tedeschi A, Bradke F. Spatial and temporal arrangement of neuronal intrinsic and extrinsic mechanisms controlling axon regeneration. Curr Opin Neurobiol. 2016;42:118–27

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Medana IM, Esiri MM. Axonal damage: a key predictor of outcome in human CNS diseases. Brain. 2003;126:515–30

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Gaetz M. The neurophysiology of brain injury. Clin Neurophysiol. 2004;115:4–18

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Smith DH, Nonaka M, Miller R, Leoni M, Chen XH, Alsop D, Meaney DF. Immediate coma following inertial brain injury dependent on axonal damage in the brainstem. J Neurosurg. 2000;93:315–22

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Tang-Schomer MD, Johnson VE, Baas PW, Stewart W, Smith DH. Partial interruption of axonal transport due to microtubule breakage accounts for the formation of periodic varicosities after traumatic axonal injury. Exp Neurol. 2012;233:364–72

    PubMed  Article  Google Scholar 

  8. 8.

    Salvadores N, Sanhueza M, Manque P, Court FA. Axonal degeneration during aging and its functional role in neurodegenerative disorders. Front Neurosci. 2017;11:451

    PubMed  PubMed Central  Article  Google Scholar 

  9. 9.

    Adalbert R, Coleman MP. Axon pathology in age-related neurodegenerative disorders. Neuropathol Appl Neurobiol. 2012;39:90–108

    Article  CAS  Google Scholar 

  10. 10.

    Sturrock RR. Age-related changes in the number of myelinated axons and glial cells in the anterior and posterior limbs of the mouse anterior commissure. J Anat. 1987;150:111–27

    CAS  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Marner L, Nyengaard JR, Tang Y, Pakkenberg B. Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol. 2003;462:144–52

    PubMed  Article  Google Scholar 

  12. 12.

    Calkins DJ: Age-Related Changes in the Visual Pathways: Blame It on the AxonAge-Related Changes in the Visual Pathways. Invest Ophthalmol Vis Sci 2013, 54:ORSF 37-41.

    Article  Google Scholar 

  13. 13.

    Blackstone C, O'Kane CJ, Reid E. Hereditary spastic paraplegias: membrane traffic and the motor pathway. Nat Rev Neurosci. 2011;12:31–42

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  14. 14.

    Riancho J, Gonzalo I, Ruiz-Soto M, Berciano J. Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis. Neurología. 2019;34:27–37

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Aguzzi A: ‘Forward genetics’ and the causes of ALS. Nature Reviews Molecular Cell Biology 2019, 20:67-67.

    Article  CAS  Google Scholar 

  16. 16.

    Hirokawa N: Molecular architecture and dynamics of the neuronal cytoskeleton. In The neuronal cytoskeleton. Edited by Burgoyne R. New York: Wiley-Liss; 1991: 5-74

  17. 17.

    Fath KR, Lasek RJ. Two classes of actin microfilaments are associated with the inner cytoskeleton of axons. J Cell Biol. 1988;107:613–21

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Ganguly A, Tang Y, Wang L, Ladt K, Loi J, Dargent B, Leterrier C, Roy S. A dynamic formin-dependent deep F-actin network in axons. J Cell Biol. 2015;210:401–17

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Hirokawa N. Cross-linker system between neurofilaments, microtubules, and membranous organelles in frog axons revealed by the quick-freeze, deep-etching method. J Cell Biol. 1982;94:129–42

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    Xu K, Zhong G, Zhuang X. Actin, Spectrin, and associated proteins form a periodic cytoskeletal structure in axons. Science. 2013;339:452–6

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Qu Y, Hahn I, Webb SED, Pearce SP, Prokop A. Periodic actin structures in neuronal axons are required to maintain microtubules. Mol Biol Cell. 2017;28:296–308

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  22. 22.

    Vassilopoulos S, Gibaud S, Jimenez A, Caillol G, Leterrier C: Ultrastructure of the axonal periodic scaffold reveals a braid-like organization of actin rings. bioRxiv 2019:636217.

  23. 23.

    Prokop A. The intricate relationship between microtubules and their associated motor proteins during axon growth and maintenance. Neur Dev. 2013;8:17

    Article  CAS  Google Scholar 

  24. 24.

    Leterrier C, Dubey P, Roy S. The nano-architecture of the axonal cytoskeleton. Nature Reviews Neuroscience. 2017;18:713–26.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Leterrier C. The axon initial segment: an updated viewpoint. J Neurosci. 2018;38:2135–45

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    Dent EW, Gupton SL, Gertler FB. The growth cone cytoskeleton in axon outgrowth and guidance. Cold Spring Harb Perspect Biol. 2011;3:a001800

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  27. 27.

    Friede RL, Samorajski T. Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice. Anat Rec. 1970;167:379–87

    CAS  PubMed  Article  Google Scholar 

  28. 28.

    Sakaguchi T, Okada M, Kitamura T, Kawasaki K. Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail. Neurosci Lett. 1993;153:65–8

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Rao MV, Campbell J, Yuan A, Kumar A, Gotow T, Uchiyama Y, Nixon RA. The neurofilament middle molecular mass subunit carboxyl-terminal tail domains is essential for the radial growth and cytoskeletal architecture of axons but not for regulating neurofilament transport rate. J Cell Biol. 2003;163:1021–31

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Perrot R, Berges R, Bocquet A, Eyer J. Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol Neurobiol. 2008;38:27–65

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Eyer J, Cleveland DW, Wong PC, Peterson AC. Pathogenesis of two axonopathies does not require axonal neurofilaments. Nature. 1998;391:584–7

    CAS  PubMed  Article  Google Scholar 

  32. 32.

    Nguyen MD, Lariviere RC, Julien JP. Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1. Proc Natl Acad Sci U S A. 2000;97:12306–11

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  33. 33.

    Eyer J, Peterson A. Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-beta-galactosidase fusion protein. Neuron. 1994;12:389–405

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Yamasaki H, Itakura C, Mizutani M. Hereditary hypotrophic axonopathy with neurofilament deficiency in a mutant strain of the Japanese quail. Acta Neuropathol. 1991;82:427–34

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    Allen MJ, Godenschwege TA, Tanouye MA, Phelan P. Making an escape: development and function of the Drosophila giant fibre system. Semin Cell Dev Biol. 2006;17:31–41

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Hirokawa N. 270K microtubule-associated protein cross-reacting with anti-MAP 2 IgG in the crayfish peripheral nerve axon. J Cell Biol. 1986;103:33–9

    CAS  PubMed  Article  Google Scholar 

  37. 37.

    Voelzmann A, Hahn I, Pearce S, Sánchez-Soriano NP, Prokop A. A conceptual view at microtubule plus end dynamics in neuronal axons. Brain Res Bulletin. 2016;126:226–37

    CAS  Article  Google Scholar 

  38. 38.

    Sakakibara A, Ando R, Sapir T, Tanaka T. Microtubule dynamics in neuronal morphogenesis. Open Biology. 2013;3:130061

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  39. 39.

    Tas RP, Kapitein LC. Exploring cytoskeletal diversity in neurons. Science. 2018;361:231–2

    CAS  PubMed  Article  Google Scholar 

  40. 40.

    Hirokawa N, Niwa S, Tanaka Y. Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron. 2010;68:610–38

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Goldstein AY, Wang X, Schwarz TL. Axonal transport and the delivery of pre-synaptic components. Curr Opin Neurobiol. 2008;18:495–503

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  42. 42.

    Pfenninger KH. Plasma membrane expansion: a neuron's Herculean task. Nat Rev Neurosci. 2009;10:251–61

    CAS  PubMed  Article  Google Scholar 

  43. 43.

    Gondre-Lewis MC, Park JJ, Loh YP. Cellular mechanisms for the biogenesis and transport of synaptic and dense-core vesicles. Int Rev Cell Mol Biol. 2012;299:27–115

    CAS  PubMed  Article  Google Scholar 

  44. 44.

    Gonzalez C, Couve A. The axonal endoplasmic reticulum and protein trafficking: Cellular bootlegging south of the soma. Semin Cell Dev Biol. 2014;27:23–31

    CAS  PubMed  Article  Google Scholar 

  45. 45.

    Saxton WM, Hollenbeck PJ. The axonal transport of mitochondria. J Cell Sci. 2012;125:2095–104

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  46. 46.

    Prokop A, Beaven R, Qu Y, Sánchez-Soriano N. Using fly genetics to dissect the cytoskeletal machinery of neurons during axonal growth and maintenance. J Cell Sci. 2013;126:2331–41.

    CAS  Article  PubMed  Google Scholar 

  47. 47.

    Miller KE, Suter DM. An integrated cytoskeletal model of neurite outgrowth. Front Cell Neurosci. 2018;12:477

    Google Scholar 

  48. 48.

    Acebes A, Ferrus A. Cellular and molecular features of axon collaterals and dendrites. Trends Neurosci. 2000;23:557–65

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Kalil K, Dent EW. Branch management: mechanisms of axon branching in the developing vertebrate CNS. Nat Rev Neurosci. 2014;15:7–18

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    Tymanskyj SR, Yang B, Falnikar A, Lepore AC, Ma L. MAP 7 regulates axon collateral branch development in dorsal root ganglion neurons. J Neurosci. 2017;37:1648–61

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  51. 51.

    Tint I, Jean D, Baas PW, Black MM. Doublecortin associates with microtubules preferentially in regions of the axon displaying actin-rich protrusive structures. J Neurosci. 2009;29:10995–1010

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  52. 52.

    Bodaleo FJ, Gonzalez-Billault C. The presynaptic microtubule cytoskeleton in physiological and pathological conditions: lessons from Drosophila Fragile X Syndrome and Hereditary Spastic Paraplegias. Front Mol Neurosci. 2016;9:60

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  53. 53.

    Wozniak KM, Vornov JJ, Wu Y, Liu Y, Carozzi VA, Rodriguez-Menendez V, Ballarini E, Alberti P, Pozzi E, Semperboni S, et al. Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term Recovery. Cancer Res. 2018;78:817–29

    CAS  PubMed  Article  Google Scholar 

  54. 54.

    Prior R, Van Helleputte L, Benoy V, Van Den Bosch L. Defective axonal transport: A common pathological mechanism in inherited and acquired peripheral neuropathies. Neurobiol Dis. 2017;105:300–20

    CAS  PubMed  Article  Google Scholar 

  55. 55.

    Wu Y, Li J, Zhou J, Feng Y. Dynamic long-term microstructural and ultrastructural alterations in sensory nerves of rats of paclitaxel-induced neuropathic pain. Chin Med J (Engl). 2014;127:2945–52

    Google Scholar 

  56. 56.

    Malacrida A, Meregalli C, Rodriguez-Menendez V, Nicolini G. Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton. Int J Mol Sci. 2019;20:2287

    PubMed Central  Article  PubMed  Google Scholar 

  57. 57.

    Bernier G, Kothary R. Prenatal onset of axonopathy in Dystonia musculorum mice. Dev Genet. 1998;22:160–8

    CAS  PubMed  Article  Google Scholar 

  58. 58.

    Adalbert R, Nogradi A, Babetto E, Janeckova L, Walker SA, Kerschensteiner M, Misgeld T, Coleman MP. Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain. 2009;132:402–16

    PubMed  Article  Google Scholar 

  59. 59.

    Dalpe G, Leclerc N, Vallee A, Messer A, Mathieu M, De Repentigny Y, Kothary R. Dystonin is essential for maintaining neuronal cytoskeleton organization. Mol Cell Neurosci. 1998;10:243–57

    CAS  PubMed  Article  Google Scholar 

  60. 60.

    Sorbara CD, Wagner NE, Ladwig A, Nikic I, Merkler D, Kleele T, Marinkovic P, Naumann R, Godinho L, Bareyre FM, et al. Pervasive axonal transport deficits in multiple sclerosis models. Neuron. 2014;84:1183–90

    CAS  PubMed  Article  Google Scholar 

  61. 61.

    Yin X, Kidd GJ, Ohno N, Perkins GA, Ellisman MH, Bastian C, Brunet S, Baltan S, Trapp BD. Proteolipid protein-deficient myelin promotes axonal mitochondrial dysfunction via altered metabolic coupling. J Cell Biol. 2016;215:531–42

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  62. 62.

    Denton KR, Lei L, Grenier J, Rodionov V, Blackstone C, Li XJ. Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia. Stem Cells. 2014;32:414–23

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  63. 63.

    Havlicek S, Kohl Z, Mishra HK, Prots I, Eberhardt E, Denguir N, Wend H, Plotz S, Boyer L, Marchetto MC, et al. Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons. Hum Mol Genet. 2014;23:2527–41

    CAS  PubMed  Article  Google Scholar 

  64. 64.

    Tarrade A, Fassier C, Courageot S, Charvin D, Vitte J, Peris L, Thorel A, Mouisel E, Fonknechten N, Roblot N, et al. A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Hum Mol Genet. 2006;15:3544–58

    CAS  PubMed  Article  Google Scholar 

  65. 65.

    Fassier C, Tarrade A, Peris L, Courageot S, Mailly P, Dalard C, Delga S, Roblot N, Lefevre J, Job D, et al. Microtubule-targeting drugs rescue axonal swellings in cortical neurons from spastin knockout mice. Dis Model Mech. 2013;6:72–83

    CAS  PubMed  Article  Google Scholar 

  66. 66.

    Hsu J-M, Chen C-H, Chen Y-C, McDonald KL, Gurling M, Lee A, Garriga G, Pan C-L. Genetic analysis of a novel tubulin mutation that redirects synaptic vesicle targeting and causes neurite degeneration in C. elegans. PLoS Genet. 2014;10:e1004715.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  67. 67.

    Fiala JC, Feinberg M, Peters A, Barbas H. Mitochondrial degeneration in dystrophic neurites of senile plaques may lead to extracellular deposition of fine filaments. Brain Struct Funct. 2007;212:195–207

    PubMed  Article  Google Scholar 

  68. 68.

    Sánchez-Soriano N, Tear G, Whitington P, Prokop A. Drosophila as a genetic and cellular model for studies on axonal growth. Neural Develop. 2007;2:9

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  69. 69.

    Elden AC, Kim H-J, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  70. 70.

    Prokop A. Why funding fruit fly research is important for the biomedical sciences. Open Access Govern. 2018;20:198–201

    Google Scholar 

  71. 71.

    Bellen HJ, Tong C, Tsuda H. 100 years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future. Nat Rev Neurosci. 2010;11:514–22

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  72. 72.

    Beaven R, Dzhindzhev NS, Qu Y, Hahn I, Dajas-Bailador F, Ohkura H, Prokop A. Drosophila CLIP-190 and mammalian CLIP-170 display reduced microtubule plus end association in the nervous system. Mol Biol Cell. 2015;26:1491–508

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  73. 73.

    Gonçalves-Pimentel C, Gombos R, Mihály J, Sánchez-Soriano N, Prokop A. Dissecting regulatory networks of filopodia formation in a Drosophila growth cone model. PLoS One. 2011;6:e18340

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  74. 74.

    Qu Y, Hahn I, Lees M, Parkin J, Voelzmann A, Dorey K, Rathbone A, Friel C, Allan V, Okenve Ramos P, et al: Efa6 protects axons and regulates their growth and branching by inhibiting microtubule polymerisation at the cortex. bioRxiv 2018, 10.1101/385658

  75. 75.

    Alves-Silva J, Sánchez-Soriano N, Beaven R, Klein M, Parkin J, Millard T, Bellen H, Venken KJT, Ballestrem C, Kammerer RA, Prokop A. Spectraplakins promote microtubule-mediated axonal growth by functioning as structural microtubule-associated proteins and EB1-dependent +TIPs (Tip Interacting Proteins). J Neurosci. 2012;32:9143–58

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  76. 76.

    Voelzmann A, Okenve-Ramos P, Qu Y, Chojnowska-Monga M, del Caño-Espinel M, Prokop A, Sánchez-Soriano N. Tau and spectraplakins promote synapse formation and maintenance through Jun kinase and neuronal trafficking. eLife. 2016;5:e14694

    PubMed  PubMed Central  Article  Google Scholar 

  77. 77.

    Sánchez-Soriano N, Gonçalves-Pimentel C, Beaven R, Haessler U, Ofner L, Ballestrem C, Prokop A. Drosophila growth cones: a genetically tractable platform for the analysis of axonal growth dynamics. Dev Neurobiol. 2010;70:58–71

    PubMed  Google Scholar 

  78. 78.

    Prokop A, Küppers-Munther B, Sánchez-Soriano N: Using primary neuron cultures of Drosophila to analyse neuronal circuit formation and function. In The making and un-making of neuronal circuits in Drosophila. Volume 69. Edited by Hassan BA. New York: Humana Press; 2012: 225-247.[Walz W (Series Editor): Neuromethods].

    Google Scholar 

  79. 79.

    Hahn I, Ronshaugen M, Sánchez-Soriano N, Prokop A. Functional and genetic analysis of spectraplakins in Drosophila. Methods Enzymol. 2016;569:373–405

    CAS  PubMed  Article  Google Scholar 

  80. 80.

    Roote J, Prokop A. How to design a genetic mating scheme: a basic training package for Drosophila genetics. G3 (Bethesda). 2013;3:353–8

    Article  Google Scholar 

  81. 81.

    Yogev S, Cooper R, Fetter R, Horowitz M, Shen K. Microtubule organization determines axonal transport dynamics. Neuron. 2016;92:449–60

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  82. 82.

    Yogev S, Maeder CI, Cooper R, Horowitz M, Hendricks AG, Shen K. Local inhibition of microtubule dynamics by dynein is required for neuronal cargo distribution. Nat Commun. 2017;8:15063

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  83. 83.

    Krieg M, Stühmer J, Cueva JG, Fetter R, Spilker K, Cremers D, Shen K, Dunn AR, Goodman MB: Genetic defects in β-spectrin and tau sensitize C. elegans axons to movement-induced damage via torque-tension coupling. Elife 2017, 6:e20172.

  84. 84.

    Fletcher DA, Mullins RD. Cell mechanics and the cytoskeleton. Nature. 2010;463:485–92

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  85. 85.

    Howard J. Mechanics of motorproteins and the cytoskeleton. Sunderland: Sinauer Assoc.; 2001.

    Google Scholar 

  86. 86.

    Hawkins T, Mirigian M, Selcuk Yasar M, Ross JL. Mechanics of microtubules. J Biomech. 2010;43:23–30

    PubMed  Article  Google Scholar 

  87. 87.

    Sánchez-Soriano N, Travis M, Dajas-Bailador F, Goncalves-Pimentel C, Whitmarsh AJ, Prokop A. Mouse ACF7 and Drosophila Short stop modulate filopodia formation and microtubule organisation during neuronal growth. Journal of cell science. 2009;122:2534–42

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  88. 88.

    Ahmad FJ, He Y, Myers KA, Hasaka TP, Francis F, Black MM, Baas PW. Effects of dynactin disruption and dynein depletion on axonal microtubules. Traffic. 2006;7:524–37

    CAS  PubMed  Article  Google Scholar 

  89. 89.

    Prokop A. Fruit flies in biological research. Biological Sciences Review. 2016;28:10–4

    Google Scholar 

  90. 90.

    Voelzmann A, Liew Y-T, Qu Y, Hahn I, Melero C, Sánchez-Soriano N, Prokop A. Drosophila Short stop as a paradigm for the role and regulation of spectraplakins. Sem Cell Dev Biol. 2017;69:40–57

    CAS  Article  Google Scholar 

  91. 91.

    Brouhard GJ, Rice LM. Microtubule dynamics: an interplay of biochemistry and mechanics. Nat Rev Mol Cell Biol. 2018;19:451–63.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  92. 92.

    van Haren J, Wittmann T. Microtubule plus end dynamics − do we know how microtubules grow? BioEssays. 2019;41:1800194.

    CAS  Article  Google Scholar 

  93. 93.

    Burton PR, Hinkley RE, Pierson GB. Tannic acid-stained microtubules with 12, 13, and 15 protofilaments. J Cell Biol. 1975;65:227–33

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  94. 94.

    Benshalom G, Reese TS. Ultrastructural observations on the cytoarchitecture of axons processed by rapid-freezing and freeze-substitution. J Neurocytol. 1985;14:943–60

    CAS  PubMed  Article  Google Scholar 

  95. 95.

    Savage C, Hamelin M, Culotti JG, Coulson A, Albertson DG. Chalfie M: mec-7 is a beta-tubulin gene required for the production of 15-protofilament microtubules in Caenorhabditis elegans. Genes Dev. 1989;3:870–81

    CAS  PubMed  Article  Google Scholar 

  96. 96.

    Chalfie M, Thomson JN. Structural and functional diversity in the neuronal microtubules of Caenorhabditis elegans. J Cell Biol. 1982;93:15–23

    CAS  PubMed  Article  Google Scholar 

  97. 97.

    Chaaban S, Brouhard GJ. A microtubule bestiary: structural diversity in tubulin polymers. Mol Biol Cell. 2017;28:2924–31

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  98. 98.

    Chrétien D, Fuller SD. Microtubules switch occasionally into unfavorable configurations during elongation. J Mol Biol. 2000;298:663–76

    PubMed  Article  CAS  Google Scholar 

  99. 99.

    Chrétien D, Wade RH. New data on the microtubule surface lattice. Biol Cell. 1991;71:161–74

    PubMed  Article  Google Scholar 

  100. 100.

    Chrétien D, Kenney JM, Fuller SD, Wade RH. Determination of microtubule polarity by cryo-electron microscopy. Structure. 1996;4:1031–40

    PubMed  Article  Google Scholar 

  101. 101.

    Ray S, Meyhofer E, Milligan RA, Howard J. Kinesin follows the microtubule's protofilament axis. J Cell Biol. 1993;121:1083–93

    CAS  PubMed  Article  Google Scholar 

  102. 102.

    Shaw G, Bray D. Movement and extension of isolated growth cones. Exp Cell Res. 1977;104:55–62

    CAS  PubMed  Article  Google Scholar 

  103. 103.

    Vemu A, Atherton J, Spector JO, Moores CA, Roll-Mecak A. Tubulin isoform composition tunes microtubule dynamics. Mol Biol Cell. 2017;28:3564–72

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  104. 104.

    Park JH, Roll-Mecak A. The tubulin code in neuronal polarity. Curr Opin Neurobiol. 2018;51:95–102

    CAS  PubMed  Article  Google Scholar 

  105. 105.

    Ti S-C, Alushin GM, Kapoor TM. Human β-tubulin isotypes can regulate microtubule protofilament number and stability. Developmental Cell. 2018;47:175–190.e175

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  106. 106.

    Janke C, Kneussel M. Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton. Trends Neurosci. 2010;33:362–72

    CAS  PubMed  Article  Google Scholar 

  107. 107.

    Valenstein ML, Roll-Mecak A. Graded control of microtubule severing by tubulin glutamylation. Cell. 2016;164:911–21

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  108. 108.

    Boucher D, Larcher JC, Gros F, Denoulet P. Polyglutamylation of tubulin as a progressive regulator of in vitro interactions between the microtubule-associated protein Tau and tubulin. Biochemistry. 1994;33:12471–7

    CAS  PubMed  Article  Google Scholar 

  109. 109.

    Song Y, Kirkpatrick LL, Schilling AB, Helseth DL, Chabot N, Keillor JW, Johnson GV, Brady ST. Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules. Neuron. 2013;78:109–23

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  110. 110.

    Soppina V, Herbstman JF, Skiniotis G, Verhey KJ. Luminal localization of alpha-tubulin K40 acetylation by cryo-EM analysis of fab-labeled microtubules. PLoS One. 2012;7:e48204

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  111. 111.

    Xu Z, Schaedel L, Portran D, Aguilar A, Gaillard J, Marinkovich MP, Théry M, Nachury MV. Microtubules acquire resistance from mechanical breakage through intralumenal acetylation. Science. 2017;356:328–32

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  112. 112.

    Howes SC, Alushin GM, Shida T, Nachury MV, Nogales E. Effects of tubulin acetylation and tubulin acetyltransferase binding on microtubule structure. Mol Biol Cell. 2014;25:257–66

    PubMed  PubMed Central  Article  Google Scholar 

  113. 113.

    Baas PW, Rao AN, Matamoros AJ, Leo L. Stability properties of neuronal microtubules. Cytoskeleton (Hoboken). 2016;73:442–60

    CAS  Article  Google Scholar 

  114. 114.

    Portran D, Schaedel L, Xu Z, Thery M, Nachury MV. Tubulin acetylation protects long-lived microtubules against mechanical ageing. Nat Cell Biol. 2017;19:391–8

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  115. 115.

    Yan C, Wang F, Peng Y, Williams CR, Jenkins B, Wildonger J, Kim HJ, Perr JB, Vaughan JC, Kern ME, et al: Microtubule acetylation is required for mechanosensation in Drosophila. Cell Rep 2018, 25:1051-1065 e1056.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  116. 116.

    Jenkins BV, Saunders HAJ, Record HL, Johnson-Schlitz DM, Wildonger J. Effects of mutating alpha-tubulin lysine 40 on sensory dendrite development. J Cell Sci. 2017;130:4120–31

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  117. 117.

    Ichikawa M, Bui KH. Microtubule inner proteins: a meshwork of luminal proteins stabilizing the doublet microtubule. BioEssays. 2018;40:1700209.

    CAS  Article  Google Scholar 

  118. 118.

    Bechstedt S, Lu K, Brouhard Gary J. Doublecortin recognizes the longitudinal curvature of the microtubule end and lattice. Curr Biol. 2014;24:2366–75

    CAS  PubMed  Article  Google Scholar 

  119. 119.

    Ettinger A, van Haren J, Ribeiro SA, Wittmann T. Doublecortin is excluded from growing microtubule ends and recognizes the GDP-microtubule lattice. Curr Biol. 2016;26:1549–55

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  120. 120.

    Peet DR, Burroughs NJ, Cross RA. Kinesin expands and stabilizes the GDP-microtubule lattice. Nat Nanotechnol. 2018;13:386–91

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  121. 121.

    Sumino Y, Nagai KH, Shitaka Y, Tanaka D, Yoshikawa K, Chate H, Oiwa K. Large-scale vortex lattice emerging from collectively moving microtubules. Nature. 2012;483:448–52

    CAS  PubMed  Article  Google Scholar 

  122. 122.

    Kerssemakers J, Howard J, Hess H, Diez S. The distance that kinesin-1 holds its cargo from the microtubule surface measured by fluorescence interference contrast microscopy. Proc Natl Acad Sci U S A. 2006;103:15812–7

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  123. 123.

    Palacci H, Idan O, Armstrong MJ, Agarwal A, Nitta T, Hess H. Velocity fluctuations in kinesin-1 gliding motility assays originate in motor attachment geometry variations. Langmuir. 2016;32:7943–50

    CAS  PubMed  Article  Google Scholar 

  124. 124.

    VanDelinder V, Imam ZI, Bachand G. Kinesin motor density and dynamics in gliding microtubule motility. Scientific Reports. 2019;9:7206.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  125. 125.

    Lam AT, VanDelinder V, Kabir AMR, Hess H, Bachand GD, Kakugo A. Cytoskeletal motor-driven active self-assembly in in vitro systems. Soft Matter. 2016;12:988–97.

    CAS  Article  PubMed  Google Scholar 

  126. 126.

    Amos L, Amos W. The bending of sliding microtubules imaged by confocal light microscopy and negative stain electron microscopy. J Cell Sci. 1991;1991:95–101

    Article  Google Scholar 

  127. 127.

    Weiss D, Langford G, Seitz-Tutter D, Maile W. Analysis of the gliding, fishtailing and circling motions of native microtubules. Acta Histochem Suppl. 1991;41:81–105.

    CAS  PubMed  Google Scholar 

  128. 128.

    Waterman-Storer CM, Salmon ED. Actomyosin-based retrograde flow of microtubules in the lamella of migrating epithelial cells influences microtubule dynamic instability and turnover and is associated with microtubule breakage and treadmilling. J Cell Biol. 1997;139:417–34

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  129. 129.

    Odde DJ, Ma L, Briggs AH, DeMarco A, Kirschner MW. Microtubule bending and breaking in living fibroblast cells. Journal of cell science. 1999;112:3283–8

    CAS  PubMed  Google Scholar 

  130. 130.

    Hess H, Clemmens J, Brunner C, Doot R, Luna S, Ernst KH, Vogel V. Molecular self-assembly of "nanowires"and "nanospools" using active transport. Nano Lett. 2005;5:629–33

    CAS  PubMed  Article  Google Scholar 

  131. 131.

    Dent EW, Kalil K. Axon branching requires interactions between dynamic microtubules and actin filaments. J Neurosci. 2001;21:9757–69

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  132. 132.

    Liu H, Spoerke ED, Bachand M, Koch SJ, Bunker BC, Bachand GD. Biomolecular Motor-Powered Self-Assembly of Dissipative Nanocomposite Rings. Advanced Materials. 2008;20:4476–81.

    CAS  Article  Google Scholar 

  133. 133.

    VanDelinder V, Brener S, Bachand GD. Mechanisms underlying the active self-assembly of microtubule rings and spools. Biomacromolecules. 2016;17:1048–56

    CAS  PubMed  Article  Google Scholar 

  134. 134.

    Liu L, Tuzel E, Ross JL. Loop formation of microtubules during gliding at high density. J Phys Condens Matter. 2011;23:374104

    PubMed  Article  CAS  Google Scholar 

  135. 135.

    Lam AT, Curschellas C, Krovvidi D, Hess H. Controlling self-assembly of microtubule spools via kinesin motor density. Soft Matter. 2014;10:8731–6.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  136. 136.

    Wada S, Rashedul Kabir AM, Ito M, Inoue D, Sada K, Kakugo A. Effect of length and rigidity of microtubules on the size of ring-shaped assemblies obtained through active self-organization. Soft Matter. 2015;11:1151–7.

    CAS  Article  PubMed  Google Scholar 

  137. 137.

    Kawamura R, Kakugo A, Shikinaka K, Osada Y, Gong JP. Ring-Shaped Assembly of Microtubules Shows Preferential Counterclockwise Motion. Biomacromolecules. 2008;9:2277–82.

    CAS  Article  PubMed  Google Scholar 

  138. 138.

    Rashedul Kabir AM, Wada S, Inoue D, Tamura Y, Kajihara T, Mayama H, Sada K, Kakugo A, Gong JP. Formation of ring-shaped assembly of microtubules with a narrow size distribution at an air-buffer interface. Soft Matter. 2012;8:10863–7

    CAS  Article  Google Scholar 

  139. 139.

    Alberti S, Hyman AA. Are aberrant phase transitions a driver of cellular aging? BioEssays. 2016;38:959–68

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  140. 140.

    Nakashima KK, Vibhute MA, Spruijt E. Biomolecular Chemistry in Liquid Phase Separated Compartments. Frontiers in Molecular Biosciences. 2019;6:21

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  141. 141.

    Ziebert F, Mohrbach H, Kulić IM. Why Microtubules Run in Circles: Mechanical Hysteresis of the Tubulin Lattice. Physical Review Letters. 2015;114:148101.

    CAS  Article  PubMed  Google Scholar 

  142. 142.

    Arnal I, Wade RH. How does taxol stabilize microtubules? Curr Biol. 1995;5:900–8

    CAS  PubMed  Article  Google Scholar 

  143. 143.

    Alushin GM, Lander GC, Kellogg EH, Zhang R, Baker D, Nogales E. High-resolution microtubule structures reveal the structural transitions in alphabeta-tubulin upon GTP hydrolysis. Cell. 2014;157:1117–29

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  144. 144.

    Castle BT, McCubbin S, Prahl LS, Bernens JN, Sept D, Odde DJ. Mechanisms of kinetic stabilization by the drugs paclitaxel and vinblastine. Mol Biol Cell. 2017;28:1238–57.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  145. 145.

    Hyman AA, Chretien D, Arnal I, Wade RH. Structural changes accompanying GTP hydrolysis in microtubules: information from a slowly hydrolyzable analogue guanylyl-(alpha,beta)-methylene-diphosphonate. J Cell Biol. 1995;128:117–25

    CAS  PubMed  Article  Google Scholar 

  146. 146.

    Amos LA, Löwe J. How taxol stabilises microtubule structure. Chem Biol. 1999;6:R65–9

    CAS  PubMed  Article  Google Scholar 

  147. 147.

    Geyer EA, Burns A, Lalonde BA, Ye X, Piedra F-A, Huffaker TC, Rice LM. A mutation uncouples the tubulin conformational and GTPase cycles, revealing allosteric control of microtubule dynamics. Elife. 2015;4:e10113.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  148. 148.

    Machin NA, Lee JM, Barnes G. Microtubule stability in budding yeast: characterization and dosage suppression of a benomyl-dependent tubulin mutant. Mol Biol Cell. 1995;6:1241–59.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  149. 149.

    Balabanian L, Berger CL, Hendricks AG. Acetylated microtubules are preferentially bundled leading to enhanced kinesin-1 motility. Biophys J. 2017;113:1551–60

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  150. 150.

    Samsonov A, Yu JZ, Rasenick M, Popov SV. Tau interaction with microtubules in vivo. J Cell Sci. 2004;117:6129–41

    CAS  PubMed  Article  Google Scholar 

  151. 151.

    Fourniol FJ, Sindelar CV, Amigues B, Clare DK, Thomas G, Perderiset M, Francis F, Houdusse A, Moores CA. Template-free 13-protofilament microtubule–MAP assembly visualized at 8 Å resolution. J Cell Biol. 2010;191:463–70

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  152. 152.

    Krebs A, Goldie KN, Hoenger A. Complex formation with kinesin motor domains affects the structure of microtubules. J Mol Biol. 2004;335:139–53

    CAS  PubMed  Article  Google Scholar 

  153. 153.

    Morikawa M, Yajima H, Nitta R, Inoue S, Ogura T, Sato C, Hirokawa N. X-ray and Cryo-EM structures reveal mutual conformational changes of Kinesin and GTP-state microtubules upon binding. EMBO J. 2015;34:1270–86

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  154. 154.

    Muto E, Sakai H, Kaseda K. Long-range cooperative binding of kinesin to a microtubule in the presence of ATP. J Cell Biol. 2005;168:691–6

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  155. 155.

    Cross RA. Microtubule lattice plasticity. Curr Opin Cell Biol. 2019;56:88–93

    CAS  PubMed  Article  Google Scholar 

  156. 156.

    Pearce SP, Heil M, Jensen OE, Jones GW, Prokop A. Curvature-sensitive kinesin binding can explain microtubule ring formation and reveals chaotic dynamics in a mathematical model. Bull Math Biol. 2018;80:3002–22

    PubMed  Article  Google Scholar 

  157. 157.

    Man Y, Kanso E. Morphological transitions of axially-driven microfilaments. Soft Matter. 2019;15:5163–73.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  158. 158.

    Memet E, Hilitski F, Morris MA, Schwenger WJ, Dogic Z, Mahadevan L. Microtubules soften due to cross-sectional flattening. Elife. 2018;7:e34695

    PubMed  PubMed Central  Article  Google Scholar 

  159. 159.

    Kononova O, Kholodov Y, Theisen KE, Marx KA, Dima RI, Ataullakhanov FI, Grishchuk EL, Barsegov V. Tubulin bond energies and microtubule biomechanics determined from nanoindentation in silico. J Am Chem Soc. 2014;136:17036–45

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  160. 160.

    Kabir AM, Inoue D, Hamano Y, Mayama H, Sada K, Kakugo A. Biomolecular motor modulates mechanical property of microtubule. Biomacromolecules. 2014;15:1797–805

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  161. 161.

    Sturgill EG, Ohi R. Microtubule-regulating kinesins. Current Biology. 2013;23:R946–8

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  162. 162.

    Guzik-Lendrum S, Rayment I, Gilbert SP. Homodimeric kinesin-2 KIF3CC promotes microtubule dynamics. Biophys J. 2017;113:1845–57

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  163. 163.

    Chen Y, Hancock WO. Kinesin-5 is a microtubule polymerase. Nat Commun. 2015;6:8160

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  164. 164.

    Gumy LF, Chew DJ, Tortosa E, Katrukha EA, Kapitein LC, Tolkovsky AM, Hoogenraad CC, Fawcett JW. The kinesin-2 family member KIF3C regulates microtubule dynamics and is required for axon growth and regeneration. J Neurosci. 2013;33:11329–45

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  165. 165.

    Walczak CE, Gayek S, Ohi R. Microtubule-depolymerizing kinesins. Annu Rev Cell Dev Biol. 2013;29:417–41

    CAS  PubMed  Article  Google Scholar 

  166. 166.

    Strothman C, Farmer V, Arpağ G, Rodgers N, Podolski M, Norris S, Ohi R, Zanic M: Microtubule minus-end stability is dictated by the tubulin off-rate. J Cell Biol 2019:jcb.201905019.

  167. 167.

    Tas RP, Chazeau A, Cloin BMC, Lambers MLA, Hoogenraad CC, Kapitein LC. Differentiation between oppositely oriented microtubules controls polarized neuronal transport. Neuron. 2017;96:1264–71

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  168. 168.

    Zheng Y, Wildonger J, Ye B, Zhang Y, Kita A, Younger SH, Zimmerman S, Jan LY, Jan YN. Dynein is required for polarized dendritic transport and uniform microtubule orientation in axons. Nat Cell Biol. 2008;10:1172–80

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  169. 169.

    Chen Y, Rolls MM, Hancock WO. An EB1-kinesin complex is sufficient to steer microtubule growth in vitro. Curr Biol. 2014;24:316–21

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  170. 170.

    Allan VJ. Cytoplasmic dynein. Biochem Soc Trans. 2011;39:1169–78

    CAS  PubMed  Article  Google Scholar 

  171. 171.

    Appert-Rolland C, Ebbinghaus M, Santen L. Intracellular transport driven by cytoskeletal motors: General mechanisms and defects. Physics Reports. 2015;593:1–59

    CAS  Article  Google Scholar 

  172. 172.

    Wortman JC, Shrestha UM, Barry DM, Garcia ML, Gross SP, Yu CC. Axonal transport: how high microtubule density can compensate for boundary effects in small-caliber axons. Biophys J. 2014;106:813–23

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  173. 173.

    Pannese E, Ledda M, Arcidiacono G, Rigamonti L, Procacci P. A comparison of the density of microtubules in the central and peripheral axonal branches of the pseudounipolar neurons of lizard spinal ganglia. Anat Rec. 1984;208:595–605

    CAS  PubMed  Article  Google Scholar 

  174. 174.

    Fadić R, Vergara J, Alvarez J. Microtubules and caliber of central and peripheral processes of sensory axons. J Comp Neurol. 1985;236:258–64.

    Article  PubMed  Google Scholar 

  175. 175.

    Sirajuddin M, Rice LM, Vale RD. Regulation of microtubule motors by tubulin isotypes and post-translational modifications. Nat Cell Biol. 2014;16:335–44.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  176. 176.

    Monroy BY, Sawyer DL, Ackermann BE, Borden MM, Tan TC, Ori-McKenney KM. Competition between microtubule-associated proteins directs motor transport. Nat Commun. 2018;9:1487.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  177. 177.

    Subramaniyan Parimalam S, Tarhan MC, Karsten SL, Fujita H, Shintaku H, Kotera H, Yokokawa R. On-chip microtubule gliding assay for parallel measurement of tau protein species. Lab on a Chip. 2016;16:1691–7.

    CAS  Article  PubMed  Google Scholar 

  178. 178.

    Nakata T, Niwa S, Okada Y, Perez F, Hirokawa N. Preferential binding of a kinesin-1 motor to GTP-tubulin-rich microtubules underlies polarized vesicle transport. J Cell Biol. 2011;194:245–55

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  179. 179.

    Siahaan V, Krattenmacher J, Hernandez-Vega A, Hyman AA, Diez S, Lansky Z, Braun M. Kinetically distinct phases of tau on microtubules regulate kinesin motors and severing enzymes. Nat Cell Biol. 2019;21:1086–92.

    CAS  Article  PubMed  Google Scholar 

  180. 180.

    Tan R, Lam AJ, Tan T, Han J, Nowakowski DW, Vershinin M, Simo S, Ori-McKenney KM, McKenney RJ. Microtubules gate tau condensation to spatially regulate microtubule functions. Nat Cell Biol. 2019;21:1078–85.

    CAS  Article  PubMed  Google Scholar 

  181. 181.

    Dumont E. L. P., Do C, Hess H: Molecular wear of microtubules propelled by surface-adhered kinesins. Nat Nano. 2015;10:166–9.

    CAS  Article  Google Scholar 

  182. 182.

    VanDelinder V, Adams PG, Bachand GD. Mechanical splitting of microtubules into protofilament bundles by surface-bound kinesin-1. Sci Rep. 2016;6:39408

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  183. 183.

    Triclin S, Inoue D, Gaillard J, Htet ZM, De Santis M, Portran D, Derivery E, Aumeier C, Schaedel L, John K, et al: Self-repair protects microtubules from their destruction by molecular motors. bioRxiv 2018:499020.

  184. 184.

    Akhmanova A. Strengthening Microtubules by Cuts that Heal. Dev Cell. 2018;47:400–1

    CAS  PubMed  Article  Google Scholar 

  185. 185.

    Schaedel L, John K, Gaillard J, Nachury MV, Blanchoin L, Thery M. Microtubules self-repair in response to mechanical stress. Nat Mater. 2015;14:1156–63

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  186. 186.

    Baker D, O'Neill JK, Gschmeissner SE, Wilcox CE, Butter C, Turk JL. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J Neuroimmunol. 1990;28:261–70

    CAS  PubMed  Article  Google Scholar 

  187. 187.

    Abdul-Majid KB, Jirholt J, Stadelmann C, Stefferl A, Kjellen P, Wallstrom E, Holmdahl R, Lassmann H, Olsson T, Harris RA. Screening of several H-2 congenic mouse strains identified H-2(q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement. J Neuroimmunol. 2000;111:23–33

    CAS  PubMed  Article  Google Scholar 

  188. 188.

    Kuijpers M, van de Willige D, Freal A, Chazeau A, Franker Mariella A, Hofenk J, Rodrigues Ricardo JC, Kapitein Lukas C, Akhmanova A, Jaarsma D, Hoogenraad Casper C. Dynein regulator NDEL1 controls polarized cargo transport at the axon initial segment. Neuron. 2016;89:461–71

    CAS  PubMed  Article  Google Scholar 

  189. 189.

    Stokin GB, Almenar-Queralt A, Gunawardena S, Rodrigues EM, Falzone T, Kim J, Lillo C, Mount SL, Roberts EA, McGowan E, et al. Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides. Hum Mol Genet. 2008;17:3474–86

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  190. 190.

    Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science. 2005;307:1282–8

    CAS  PubMed  Article  Google Scholar 

  191. 191.

    Bucci C, Bakke O, Progida C. Charcot-Marie-Tooth disease and intracellular traffic. Prog Neurobiol. 2012;99:191–225

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  192. 192.

    Blackstone C. Hereditary spastic paraplegia. Handb Clin Neurol. 2018;148:633–52

    PubMed  Article  Google Scholar 

  193. 193.

    Brunden KR, Trojanowski JQ, Smith AB 3rd, Lee VM, Ballatore C. Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease. Bioorg Med Chem. 2014;22:5040–9

    CAS  PubMed  Article  Google Scholar 

  194. 194.

    Zhang B, Carroll J, Trojanowski JQ, Yao Y, Iba M, Potuzak JS, Hogan AM, Xie SX, Ballatore C, Smith AB 3rd, et al. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J Neurosci. 2012;32:3601–11

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  195. 195.

    Sheng ZH. The interplay of axonal energy homeostasis and mitochondrial trafficking and anchoring. Trends Cell Biol. 2017;27:403–16

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  196. 196.

    Skruber K, Read T-A, Vitriol EA: Reconsidering an active role for G-actin in cytoskeletal regulation. J Cell Sci 2018, 131:10.1242/jcs.203760.

  197. 197.

    Krendel M, Mooseker MS. Myosins: tails (and heads) of functional diversity. Physiology (Bethesda). 2005;20:239–51

    CAS  Google Scholar 

  198. 198.

    Bogoyevitch MA, Fairlie DP. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding. Drug Discov Today. 2007;12:622–33

    CAS  PubMed  Article  Google Scholar 

  199. 199.

    Berg JM, Tymoczko JL, Stryer L: Biochemistry (5th edition). New York: W H Freeman; 2002.

  200. 200.

    Hall A, Lalli G. Rho and Ras GTPases in axon growth, guidance, and branching. Cold Spring Harb Perspect Biol. 2010;2:a001818

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  201. 201.

    McNally FJ, Roll-Mecak A. Microtubule-severing enzymes: From cellular functions to molecular mechanism. J Cell Biol. 2018;217:4057–69

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  202. 202.

    Zala D, Hinckelmann M-V, Yu H, da Cunha L, Menezes M, Liot G, Cordelières Fabrice P, Marco S, Saudou F. Vesicular glycolysis provides on-board energy for fast axonal transport. Cell. 2013;152:479–91

    CAS  PubMed  Article  Google Scholar 

  203. 203.

    Hinckelmann MV, Virlogeux A, Niehage C, Poujol C, Choquet D, Hoflack B, Zala D, Saudou F. Self-propelling vesicles define glycolysis as the minimal energy machinery for neuronal transport. Nat Commun. 2016;7:13233

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  204. 204.

    McBride HM, Neuspiel M, Wasiak S. Mitochondria: more than just a powerhouse. Curr Biol. 2006;16:R551–60

    CAS  PubMed  Article  Google Scholar 

  205. 205.

    Wu Y, Whiteus C, Xu CS, Hayworth KJ, Weinberg RJ, Hess HF, De Camilli P. Contacts between the endoplasmic reticulum and other membranes in neurons. Proc Natl Acad Sci U S A. 2017;114:E4859–e4867

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  206. 206.

    Rieusset J. Endoplasmic reticulum-mitochondria calcium signaling in hepatic metabolic diseases. Biochim Biophys Acta Mol Cell Res. 1864;2017:865–76

    Google Scholar 

  207. 207.

    Kapur M, Wang W, Maloney MT, Millan I, Lundin VF, Tran TA, Yang Y. Calcium tips the balance: a microtubule plus end to lattice binding switch operates in the carboxyl terminus of BPAG1n4. EMBO Rep. 2012;13:1021–9

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  208. 208.

    McVicker DP, Millette MM, Dent EW. Signaling to the microtubule cytoskeleton: an unconventional role for CaMKII. Dev Neurobiol. 2015;75:423–34

    CAS  PubMed  Article  Google Scholar 

  209. 209.

    O'Brien ET, Salmon ED, Erickson HP. How calcium causes microtubule depolymerization. Cell Motility. 1997;36:125–35

    CAS  Article  Google Scholar 

  210. 210.

    Fransen M, Lismont C, Walton P. The Peroxisome-Mitochondria Connection: How and Why? Int J Mol Sci. 2017;18:E1126

    PubMed  Article  CAS  Google Scholar 

  211. 211.

    Pascual-Ahuir A, Manzanares-Estreder S, Proft M. Pro- and antioxidant functions of the peroxisome-mitochondria connection and its impact on aging and disease. Oxid Med Cell Longev. 2017;2017:9860841

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  212. 212.

    Wilson C, Gonzalez-Billault C. Regulation of cytoskeletal dynamics by redox signaling and oxidative stress: implications for neuronal development and trafficking. Front Cell Neurosci. 2015;9:381

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  213. 213.

    Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L. Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications. Oxid Med Cell Longev. 2017;2017:2525967

    PubMed  PubMed Central  Google Scholar 

  214. 214.

    Wali G, Sutharsan R, Fan Y, Stewart R, Tello Velasquez J, Sue CM, Crane DI, Mackay-Sim A. Mechanism of impaired microtubule-dependent peroxisome trafficking and oxidative stress in SPAST-mutated cells from patients with Hereditary Spastic Paraplegia. Sci Rep. 2016;6:27004.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  215. 215.

    Winckler B, Faundez V, Maday S, Cai Q, Guimas Almeida C, Zhang H. The endolysosomal system and proteostasis: from development to degeneration. J Neurosci. 2018;38:9364–74

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  216. 216.

    Poruchynsky MS, Sackett DL, Robey RW, Ward Y, Annunziata C, Fojo T. Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: A possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition. Cell Cycle. 2008;7:940–9.

    CAS  Article  PubMed  Google Scholar 

  217. 217.

    Staff NP, Podratz JL, Grassner L, Bader M, Paz J, Knight AM, Loprinzi CL, Trushina E, Windebank AJ. Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons. Neurotoxicology. 2013;39:124–31

    PubMed  Article  CAS  Google Scholar 

  218. 218.

    Kleele T, Marinković P, Williams PR, Stern S, Weigand EE, Engerer P, Naumann R, Hartmann J, Karl RM, Bradke F, et al. An assay to image neuronal microtubule dynamics in mice. Nat Commun. 2014;5:4827.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  219. 219.

    Stiess M, Maghelli N, Kapitein LC, Gomis-Ruth S, Wilsch-Brauninger M, Hoogenraad CC, Tolic-Norrelykke IM, Bradke F. Axon extension occurs independently of centrosomal microtubule nucleation. Science. 2010;327:704–7

    CAS  PubMed  Article  Google Scholar 

  220. 220.

    Basto R, Lau J, Vinogradova T, Gardiol A, Woods CG, Khodjakov A, Raff JW. Flies without centrioles. Cell. 2006;125:1375–86

    CAS  PubMed  Article  Google Scholar 

  221. 221.

    Sulimenko V, Hájková Z, Klebanovych A, Dráber P. Regulation of microtubule nucleation mediated by γ-tubulin complexes. Protoplasma. 2017;254:1187–99

    CAS  PubMed  Article  Google Scholar 

  222. 222.

    Tann J, Moore A: MTOC organization and competition during neuron differentiation. In The Golgi apparatus and centriole Results and problems in cell differentiation. Volume 67. Edited by M K: Springer, Cham; 2019: 337-357.

    Google Scholar 

  223. 223.

    Thawani A, Kadzik RS, Petry S. XMAP215 is a microtubule nucleation factor that functions synergistically with the γ-tubulin ring complex. Nature Cell Biology. 2018;20:575–85.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  224. 224.

    Brandt R, Lee G. The balance between tau protein's microtubule growth and nucleation activities: implications for the formation of axonal microtubules. J Neurochem. 1993;61:997–1005

    CAS  PubMed  Article  Google Scholar 

  225. 225.

    Nashchekin D, Fernandes Artur R, St Johnston D. Patronin/Shot cortical foci assemble the noncentrosomal microtubule array that specifies the Drosophila anterior-posterior axis. Dev Cell. 2016;38:61–72.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  226. 226.

    Cunha-Ferreira I, Chazeau A, Buijs RR, Stucchi R, Will L, Pan X, Adolfs Y, van der Meer C, Wolthuis JC, Kahn OI, et al. The HAUS complex is a key regulator of non-centrosomal microtubule organization during neuronal development. Cell Rep. 2018;24:791–800.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  227. 227.

    Sanchez-Huertas C, Freixo F, Viais R, Lacasa C, Soriano E, Lüders J. Non-centrosomal nucleation mediated by augmin organizes microtubules in post-mitotic neurons and controls axonal microtubule polarity. Nat Commun. 2016;7:12187.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  228. 228.

    Chen L, Stone MC, Tao J, Rolls MM. Axon injury and stress trigger a microtubule-based neuroprotective pathway. Proc Natl Acad Sci U S A. 2012;109:11842–7

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  229. 229.

    Verma V, Maresca TJ: Direct observation of branching MT nucleation in living animal cells. J Cell Biol 2019:jcb.201904114.

  230. 230.

    Al-Bassam J. Revisiting the tubulin cofactors and Arl2 in the regulation of soluble αβ-tubulin pools and their effect on microtubule dynamics. Mol Biol Cell. 2017;28:359–63

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  231. 231.

    Preitner N, Quan J, Nowakowski Dan W, Hancock Melissa L, Shi J, Tcherkezian J, Young-Pearse Tracy L, Flanagan John G. APC is an RNA-binding protein, and its interactome provides a link to neural development and microtubule assembly. Cell. 2014;158:368–82

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  232. 232.

    Gasic I, Mitchison TJ. Autoregulation and repair in microtubule homeostasis. Curr Opin Cell Biol. 2018;56:80–7

    PubMed  Article  CAS  Google Scholar 

  233. 233.

    Letourneau PC, Shattuck TA, Ressler AH. "Pull" and "push" in neurite elongation: observations on the effects of different concentrations of cytochalasin B and taxol. Cell Motil Cytoskeleton. 1987;8:193–209

    CAS  PubMed  Article  Google Scholar 

  234. 234.

    Dennerll TJ, Joshi HC, Steel VL, Buxbaum RE, Heidemann SR. Tension and compression in the cytoskeleton of PC-12 neurites. II: Quantitative measurements. J Cell Biol. 1988;107:665–74

    CAS  PubMed  Google Scholar 

  235. 235.

    Datar A, Ameeramja J, Bhat A, Srivastava R, Bernal R, Prost J, Callan-Jones A, Pullarkat PA: The roles of microtubules and membrane tension in axonal beading, retraction, and atrophy. bioRxiv 2019:10.1101/575258.

  236. 236.

    Zhou R, Han B, Xia C, Zhuang X. Membrane-associated periodic skeleton is a signaling platform for RTK transactivation in neurons. Science. 2019;365:929–34

    CAS  PubMed  Article  Google Scholar 

  237. 237.

    Zanic M, Widlund PO, Hyman AA, Howard J. Synergy between XMAP215 and EB1 increases microtubule growth rates to physiological levels. Nat Cell Biol. 2013;15:688–93.

    CAS  Article  PubMed  Google Scholar 

  238. 238.

    Gupta KK, Alberico EO, Nathke IS, Goodson HV. Promoting microtubule assembly: A hypothesis for the functional significance of the +TIP network. Bioessays. 2014;36:818–26

    CAS  PubMed  Article  Google Scholar 

  239. 239.

    Edvardson S, Cinnamon Y, Jalas C, Shaag A, Maayan C, Axelrod FB, Elpeleg O. Hereditary sensory autonomic neuropathy caused by a mutation in dystonin. Ann Neurol. 2012;71:569–72

    CAS  PubMed  Article  Google Scholar 

  240. 240.

    de Rooij R, Kuhl E, Miller KE. Modeling the axon as an active partner with the growth cone in axonal elongation. Biophys J. 2018;115:1783–95

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  241. 241.

    Fan A, Tofangchi A, Kandel M, Popescu G, Saif T. Coupled circumferential and axial tension driven by actin and myosin influences in vivo axon diameter. Sci Rep. 2017;7:14188

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  242. 242.

    Heidemann SR, Buxbaum RE. Tension as a regulator and integrator of axonal growth. Cell Motil Cytoskeleton. 1990;17:6–10

    CAS  PubMed  Article